CC01801
     RDKit          3D

 22 22  0  0  0  0  0  0  0  0999 V2000
   10.6160    5.4820   -0.2300 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9350    3.3080   -0.3420 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1650   -3.7930   -0.4060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9360   -5.2870   -0.2160 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1970   -6.0950   -0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4270   -3.2930    0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2930   -5.6270    0.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3720   -4.1470    0.7160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9180   -3.1060    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2620   -3.5100   -1.8950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4900   -1.8530    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5940   -3.7230    1.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5660   -1.0700    0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5800    0.3580    0.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3000    1.0310    0.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7270    1.0260    0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8760    2.4440    0.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0420    3.0690    0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2550    4.4870    0.4140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0830    5.3300    0.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4270    5.0940    0.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7040    4.4870   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 22  1  0
  2 22  2  0
  3  4  1  0
  3  6  1  0
  3  9  1  0
  3 10  1  0
  4  5  1  0
  5  7  1  0
  6  8  2  0
  6 11  1  0
  7  8  1  0
  8 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 21 22  1  0
M  END
>  <Name>  (1) 
13-cis-Retinoic acid

>  <InChIKey>  (1) 
SHGAZHPCJJPHSC-XFYACQKRSA-N

>  <PubChem_CID>  (1) 
9571037

>  <CYP1A2>  (1) 
<21,H;Hydroxylation;R1>

>  <CYP2A6>  (1) 
<21,H;Hydroxylation;R1>

>  <CYP2B6>  (1) 
<21,H;Hydroxylation;R1>

>  <CYP2C8>  (1) 
<21,H;Hydroxylation;R1>

>  <CYP2C9>  (1) 
<21,H;Hydroxylation;R1>

>  <CYP2C19>  (1) 
<21,H;Hydroxylation;R1>

>  <CYP2D6>  (1) 
<21,H;Hydroxylation;R1>

>  <CYP2E1>  (1) 
<21,H;Hydroxylation;R1>

>  <CYP3A4>  (1) 
<21,H;Hydroxylation;R1>

>  <References>  (1) 
Marill J, Capron CC, Idres N, Chabot GG: Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids. Biochem Pharmacol. 2002 Mar 1;63(5):933-43. doi: 10.1016/s0006-2952(01)00925-x. (PMID: 11911845)

>  <Comments>  (1) 
<7,H;Oxylation> for CYP2A6, 2C8, and 3A4. Metabolite rate for some CYP is low. Check reference.

$$$$
CC01810
     RDKit          3D

 15 16  0  0  0  0  0  0  0  0999 V2000
    1.3100    0.6530    0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1280    1.3740   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0770    0.6830   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2000    1.4530   -0.3410 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3710    0.6510   -0.4520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0800   -0.7150   -0.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140   -1.4240   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7340    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -1.4310    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7190   -0.7520    0.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7390    0.7200    0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7830    1.3540    0.4150 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5140    1.3700    0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9410   -1.4600    0.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9280   -2.0590    0.6060 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  8  1  0
  1 13  1  0
  2  3  1  0
  3  4  1  0
  3  6  2  0
  4  5  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 14  1  0
 11 12  2  0
 11 13  1  0
 14 15  3  0
M  END
>  <Name>  (2) 
3-Cyano-7-methoxycoumarin

>  <InChIKey>  (2) 
GGAFPIBJPYCFGR-UHFFFAOYSA-N

>  <PubChem_CID>  (2) 
688917

>  <CYP1A2>  (2) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2A6>  (2) 


>  <CYP2B6>  (2) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2C8>  (2) 


>  <CYP2C9>  (2) 


>  <CYP2C19>  (2) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP2D6>  (2) 


>  <CYP2E1>  (2) 
<0,H;Oxidation;R1>
<0,1;Cleavage;R1>

>  <CYP3A4>  (2) 


>  <References>  (2) 
Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL: Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos. 2002 Jul;30(7):845-52. doi: 10.1124/dmd.30.7.845. (PMID: 12065444)

>  <Comments>  (2) 


$$$$
CC01819
     RDKit          3D

 19 22  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4100    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2540    2.1320    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2390    2.1040    0.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2490   -0.6870   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1980   -0.6580    0.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4520    1.3940    0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3080    3.5210   -0.1400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4180    1.4480   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4580    0.0500   -0.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3200   -1.9950   -0.7970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3840    0.0030    0.3540 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810    2.0670    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5190    4.1500   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6880   -0.6120   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5320   -2.6010   -0.9730 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7000    3.4220   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7150   -1.9180   -0.7150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2130   -2.1030    0.7600 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  6 19  1  0
  7 12  1  0
  7 13  1  0
  8 14  2  0
  9 10  2  0
 10 15  1  0
 11 16  2  0
 13 17  2  0
 14 17  1  0
 15 18  2  0
 16 18  1  0
M  END
>  <Name>  (3) 
5-Methylchrysene

>  <InChIKey>  (3) 
GOHBXWHNJHENRX-UHFFFAOYSA-N

>  <PubChem_CID>  (3) 
19427

>  <CYP1A2>  (3) 
<4,5;EpOxidation;R1>
<13,14;EpOxidation;R2>
<6,H;Hydroxylation;R3>

>  <CYP2A6>  (3) 


>  <CYP2B6>  (3) 


>  <CYP2C8>  (3) 


>  <CYP2C9>  (3) 


>  <CYP2C19>  (3) 


>  <CYP2D6>  (3) 
<6,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<4,5;EpOxidation;R3>
<14,13;EpOxidation;R4>

>  <CYP2E1>  (3) 
<4,5;EpOxidation;R1>
<14,13;EpOxidation;R2>
<0,H;Hydroxylation;R3>

>  <CYP3A4>  (3) 
<6,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<4,5;EpOxidation;R3>
<14,13;EpOxidation;R2>

>  <References>  (3) 
Koehl W, Amin S, Staretz ME, Ueng YF, Yamazaki H, Tateishi T, Guengerich FP, Hecht SS: Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes. Cancer Res. 1996 Jan 15;56(2):316-24. (PMID: 8542586)

>  <Comments>  (3) 


$$$$
CC01828
     RDKit          3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -1.7450   -1.9170    0.7430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9230   -1.1120    0.2230 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.5030   -0.0560   -0.7820 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.2010    0.5890   -0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7160    1.7130   -1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4960    2.3110   -0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2710    1.7820    0.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8170    0.6470    0.9110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3950    0.0450    0.5610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7110   -1.0780    1.2740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6470    0.9280   -1.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9690    0.2560   -1.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1550   -1.0400   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0910   -1.9160   -0.3430 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.4150    2.2640   -2.1570 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5660    2.3890    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2920    3.1740   -0.4020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8920    2.2560   -1.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5990    3.0740   -2.4900 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1970    2.1570   -3.5280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0760    1.0920   -1.7180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1470   -2.8090   -0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1520   -2.8040    1.9020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6560   -2.7510    0.6490 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  1 10  1  0
  1 22  1  0
  1 23  1  0
  2  3  1  0
  2 14  1  0
  3  4  1  0
  3 11  1  1
  4  5  1  0
  4  9  2  0
  5  6  2  0
  5 15  1  0
  6  7  1  0
  7  8  2  0
  7 16  1  0
  8  9  1  0
  9 10  1  0
 11 12  1  0
 12 13  2  0
 12 21  1  0
 13 14  1  0
 14 24  1  1
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
M  END
>  <Name>  (4) 
7-Hydroxy-delta-8-tetrahydrocannabinol

>  <InChIKey>  (4) 
URRJUSLCXVXZOX-KNBMTAEXSA-N

>  <PubChem_CID>  (4) 
101603729

>  <CYP1A2>  (4) 
<17,18;Oxidation;R1>

>  <CYP2A6>  (4) 
<17,18;Oxidation;R1>

>  <CYP2B6>  (4) 


>  <CYP2C8>  (4) 
<17,18;Oxidation;R1>

>  <CYP2C9>  (4) 
<17,18;Oxidation;R1>

>  <CYP2C19>  (4) 


>  <CYP2D6>  (4) 


>  <CYP2E1>  (4) 


>  <CYP3A4>  (4) 
<17,18;Oxidation;R1>

>  <References>  (4) 
Matsunaga T, Kishi N, Higuchi S, Watanabe K, Ohshima T, Yamamoto I: CYP3A4 is a major isoform responsible for oxidation of 7-hydroxy-Delta(8)-tetrahydrocannabinol to 7-oxo-delta(8)-tetrahydrocannabinol in human liver microsomes. Drug Metab Dispos. 2000 Nov;28(11):1291-6. (PMID: 11038155)

>  <Comments>  (4) 


$$$$
CC01837
     RDKit          2D

 15 16  0  0  0  0  0  0  0  0999 V2000
   -1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4290    0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140   -0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7140    1.8560    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -0.2060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430   -0.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1430   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4290   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140   -1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7140    1.0310    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -2.1430   -0.6190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  2  0
  1 15  1  0
  2  3  1  0
  3  4  1  0
  3  7  2  0
  4  5  2  0
  4 14  1  0
  5  6  1  0
  5  8  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
M  END
>  <Name>  (5) 
Bropirimine

>  <InChIKey>  (5) 
CIUUIPMOFZIWIZ-UHFFFAOYSA-N

>  <PubChem_CID>  (5) 
135413497

>  <CYP1A2>  (5) 
<8,H;Hydroxylation;R1>
<6,H;Hydroxylation;R2>
<5,H;Hydroxylation;R3>
<7,8;EpOxidation;R4>
<6,7;EpOxidation;R5>

>  <CYP2A6>  (5) 


>  <CYP2B6>  (5) 


>  <CYP2C8>  (5) 


>  <CYP2C9>  (5) 


>  <CYP2C19>  (5) 


>  <CYP2D6>  (5) 


>  <CYP2E1>  (5) 


>  <CYP3A4>  (5) 


>  <References>  (5) 
Wynalda MA, Hauer MJ, Wienkers LC: Human biotransformation of bropirimine. Characterization of the major bropirimine oxidative metabolites formed in vitro. Drug Metab Dispos. 1998 Oct;26(10):1048-51. (PMID: 9763414)

>  <Comments>  (5) 


$$$$
CC01846
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.0790    1.4210   -0.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0290    0.0350   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1000    2.1890   -0.3750 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2840    2.1100   -0.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2700   -0.6180   -0.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2350   -0.6650   -0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3480    1.5810   -0.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4800    1.3980   -0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3700    0.1260   -0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4520    0.0090   -0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3890    2.2210   -0.4500 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3910   -2.1000    0.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3450   -2.6240    1.4000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0330   -2.7980    1.8150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0420   -3.3310    3.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6230    2.1390   -0.5110 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7820    1.3130   -0.4730 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  2  0
  5 12  1  0
  6 10  2  0
  7  9  1  0
  7 11  2  0
  8 10  1  0
  8 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 16 17  1  0
M  END
>  <Name>  (6) 
EMAMC

>  <InChIKey>  (6) 
WPZFUQQBKHILMS-UHFFFAOYSA-N

>  <PubChem_CID>  (6) 
85782009

>  <CYP1A2>  (6) 
<1,H;Oxidation;R1>
<1,2;Cleavage;R1>
<13,H;Oxidation;R2>
<12,13;Cleavage;R2>

>  <CYP2A6>  (6) 


>  <CYP2B6>  (6) 


>  <CYP2C8>  (6) 


>  <CYP2C9>  (6) 


>  <CYP2C19>  (6) 
<13,H;Oxidation;R1>
<12,13;Cleavage;R1>

>  <CYP2D6>  (6) 
<13,H;Oxidation;R1>
<12,13;Cleavage;R1>

>  <CYP2E1>  (6) 


>  <CYP3A4>  (6) 


>  <References>  (6) 
Venhorst J, Onderwater RC, Meerman JH, Commandeur JN, Vermeulen NP: Influence of N-substitution of 7-methoxy-4-(aminomethyl)-coumarin on cytochrome P450 metabolism and selectivity. Drug Metab Dispos. 2000 Dec;28(12):1524-32. (PMID: 11095593)

>  <Comments>  (6) 


$$$$
CC01855
     RDKit          3D

 13 13  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1760    2.0910    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020    2.0480    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6770   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2920   -0.7760    0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.4130   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1600    3.5980    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5560    2.2420    1.3900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0300   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8890    2.9890    1.4710 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.7930    4.2920    0.6750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9560    2.1500    0.9100 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  2  0
  7 10  1  0
  9 11  1  0
 11 12  1  6
 11 13  1  0
M  END
>  <Name>  (7) 
Mexiletine

>  <InChIKey>  (7) 
VLPIATFUUWWMKC-SNVBAGLBSA-N

>  <PubChem_CID>  (7) 
180621

>  <CYP1A2>  (7) 
<6,H;Hydroxylation;R1>
<0,H;Hydroxylation;R2>
<3,H;Hydroxylation;R3>
<12,H;Hydroxylation;R4>

>  <CYP2A6>  (7) 


>  <CYP2B6>  (7) 
<12,H;Hydroxylation;R1>

>  <CYP2C8>  (7) 


>  <CYP2C9>  (7) 


>  <CYP2C19>  (7) 


>  <CYP2D6>  (7) 
<2,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<0,H;Hydroxylation;R4>
<3,H;Hydroxylation;R5>
<12,H;Hydroxylation;R6>

>  <CYP2E1>  (7) 


>  <CYP3A4>  (7) 
<12,H;Hydroxylation;R1>

>  <References>  (7) 
Labbe L, Abolfathi Z, Lessard E, Pakdel H, Beaune P, Turgeon J: Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine. Xenobiotica. 2003 Jan;33(1):13-25. doi: 10.1080/0049825021000017948. (PMID: 12519691)
Nakajima M, Kobayashi K, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y: Involvement of CYP1A2 in mexiletine metabolism. Br J Clin Pharmacol. 1998 Jul;46(1):55-62. doi: 10.1046/j.1365-2125.1998.00048.x. (PMID: 9690950)

>  <Comments>  (7) 
5,7 Hydroxylation is reported in the first reference.

$$$$
CC01864
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3940    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1450   -0.6570   -0.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3060   -0.0310   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3740    1.3520   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2030    2.0870    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2940    2.1250    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2980    3.3380    0.0260 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5960    1.3670    0.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7630    2.3580    0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0850    1.5880    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2020    2.5370    0.0450 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6820    3.0880    1.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7620    2.8860   -1.0630 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6900    3.6740   -1.0540 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
M  END
>  <Name>  (8) 
NNK

>  <InChIKey>  (8) 
FLAQQSHRLBFIEZ-UHFFFAOYSA-N

>  <PubChem_CID>  (8) 
47289

>  <CYP1A2>  (8) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<0,H;Hydroxylation;R2>
<0,11;Cleavage;R2>
<1,2;Cleavage;R2>
<5,6;Cleavage;R3>

>  <CYP2A6>  (8) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<0,H;Hydroxylation;R2>
<0,1;Cleavage;R2>
<1,2;Cleavage;R2>
<11,N;N-Oxidation;R3>

>  <CYP2B6>  (8) 


>  <CYP2C8>  (8) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<0,H;Hydroxylation;R2>
<0,1;Cleavage;R2>
<1,2;Cleavage;R2>
<11,N;N-Oxidation;R3>

>  <CYP2C9>  (8) 
<11,N;N-Oxidation;R1>

>  <CYP2C19>  (8) 


>  <CYP2D6>  (8) 
<11,N;N-Oxidation;R1>

>  <CYP2E1>  (8) 
<1,2;Cleavage;R1>
<2,H;Oxidation;R1>
<0,H;Hydroxylation;R2>
<0,1;Cleavage;R2>
<1,2;Cleavage;R2>
<11,N;N-Oxidation;R3>

>  <CYP3A4>  (8) 
<1,2;Cleavage;R1>
<10,H;Oxidation;R1>
<11,N;N-Oxidation;R2>

>  <References>  (8) 
Staretz ME, Murphy SE, Patten CJ, Nunes MG, Koehl W, Amin S, Koenig LA, Guengerich FP, Hecht SS: Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes. Drug Metab Dispos. 1997 Feb;25(2):154-62. (PMID: 9029045)
Smith TJ, Guo Z, Guengerich FP, Yang CS: Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis. 1996 Apr;17(4):809-13. doi: 10.1093/carcin/17.4.809. (PMID: 8625495)
Smith TJ, Guo Z, Gonzalez FJ, Guengerich FP, Stoner GD, Yang CS: Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res. 1992 Apr 1;52(7):1757-63. (PMID: 1312898)

>  <Comments>  (8) 
Followed Xenosite.

$$$$
CC01873
     RDKit          3D

 15 16  0  0  0  0  0  0  0  0999 V2000
   -0.0240    1.6300    0.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0220    0.1680    0.1310 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.0030    2.4640    0.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4580    2.6620    0.7340 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0280   -0.5500    0.8580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2000    0.0110   -1.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7330    3.8520    1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6370    4.1860    1.1270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3200   -0.2120    0.6820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6530    4.8930    1.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0670    5.4580    1.4380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2740   -0.7700    1.4550 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6270    0.5960   -0.1730 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2160    6.1430    1.6350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1380    6.4450    1.6990 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  6
  3  7  1  0
  4  8  1  0
  5  9  1  0
  7  8  2  0
  7 10  1  0
  8 11  1  0
  9 12  1  0
  9 13  2  0
 10 14  2  0
 11 15  2  0
 14 15  1  0
M  END
>  <Name>  (9) 
Abbott-66193

>  <InChIKey>  (9) 
CKVDCQYUEYONIA-ZETCQYMHSA-N

>  <PubChem_CID>  (9) 


>  <CYP1A2>  (9) 
<9,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<11,H;Hydroxylation;R4>

>  <CYP2A6>  (9) 


>  <CYP2B6>  (9) 


>  <CYP2C8>  (9) 


>  <CYP2C9>  (9) 
<9,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<11,H;Hydroxylation;R4>
<14,S;S-Oxidation;R5>

>  <CYP2C19>  (9) 


>  <CYP2D6>  (9) 
<9,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>
<10,H;Hydroxylation;R3>
<11,H;Hydroxylation;R4>
<14,S;S-Oxidation;R5>

>  <CYP2E1>  (9) 


>  <CYP3A4>  (9) 
<14,S;S-Oxidation;R1>

>  <References>  (9) 
Machinist JM, Mayer MD, Roberts EM, Surber BW, Rodrigues AD: Identification of the human liver cytochrome P450 enzymes involved in the in vitro metabolism of a novel 5-lipoxygenase inhibitor. Drug Metab Dispos. 1998 Oct;26(10):970-6. (PMID: 9763401)

>  <Comments>  (9) 


$$$$
CC01882
     RDKit          3D

 21 21  0  0  0  0  0  0  0  0999 V2000
   -2.4230   -2.1670    0.8290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5910   -1.3550    0.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8950   -2.0620    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0360   -1.0460    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6360    0.0600   -0.9710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4870    0.8640   -0.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0150    1.6870    0.8180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9050    1.8040   -1.4150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4110   -0.0620    0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0880    0.5000    0.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9900   -0.0500   -0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2950    0.4020    0.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3970   -0.1490   -0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4490    1.4960    1.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6800    0.3290   -0.0580 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7780   -0.2080   -0.6460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1130    0.2050   -0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1930   -0.3680   -0.7550 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2700    1.2770    0.8290 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5650   -0.0290   -0.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2670   -1.2340    0.0810 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  9  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 18 20  1  0
 20 21  1  0
M  END
>  <Name>  (10) 
all-trans-Retinol

>  <InChIKey>  (10) 
FPIPGXGPPPQFEQ-OVSJKPMPSA-N

>  <PubChem_CID>  (10) 
445354

>  <CYP1A2>  (10) 
<13,14;Oxidation;R1>

>  <CYP2A6>  (10) 


>  <CYP2B6>  (10) 


>  <CYP2C8>  (10) 
<13,14;Oxidation;R1>
<20,H;Hydroxylation;R2>

>  <CYP2C9>  (10) 
<13,14;Oxidation;R1>

>  <CYP2C19>  (10) 
<13,14;Oxidation;R1>

>  <CYP2D6>  (10) 
<13,14;Oxidation;R1>

>  <CYP2E1>  (10) 


>  <CYP3A4>  (10) 
<13,14;Oxidation;R1>

>  <References>  (10) 
Leo MA, Lasker JM, Raucy JL, Kim CI, Black M, Lieber CS: Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch Biochem Biophys. 1989 Feb 15;269(1):305-12. doi: 10.1016/0003-9861(89)90112-4. (PMID: 2916844)
Chen H, Howald WN, Juchau MR: Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Drug Metab Dispos. 2000 Mar;28(3):315-22. (PMID: 10681376)

>  <Comments>  (10) 


$$$$
CC01891
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -0.1900    1.2080    0.2350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3720   -0.1630    0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7070   -1.0030    0.4310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9680   -0.4740    0.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500    0.8970    0.6360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0710    1.7370    0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3650    2.1240    0.0110 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.2050    3.3050    0.7980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6370    3.0040    2.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9860    1.7000    2.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4190    1.3940    3.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5040    2.3870    4.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1580    3.6880    4.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7240    3.9980    3.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3460    5.4160    2.6710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4410    2.5040   -1.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7030    3.3320   -1.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7760    3.6970   -3.1410 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0030    4.4850   -3.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
  7 16  1  6
  8  9  1  0
  9 10  2  0
  9 14  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
M  END
>  <Name>  (11) 
Atomoxetine

>  <InChIKey>  (11) 
VHGCDTVCOLNTBX-KRWDZBQOSA-N

>  <PubChem_CID>  (11) 
6093336

>  <CYP1A2>  (11) 
<9,H;Hydroxylation;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2A6>  (11) 


>  <CYP2B6>  (11) 
<9,H;Hydroxylation;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2C8>  (11) 


>  <CYP2C9>  (11) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2C19>  (11) 
<9,H;Hydroxylation;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>

>  <CYP2D6>  (11) 
<9,H;Hydroxylation;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>
<12,H;Hydroxylation;R3>

>  <CYP2E1>  (11) 
<9,H;Hydroxylation;R1>

>  <CYP3A4>  (11) 
<9,H;Hydroxylation;R1>
<0,H;Oxidation;R2>
<0,1;Cleavage;R2>
> <References>
Ring BJ, Gillespie JS, Eckstein JA, Wrighton SA: Identification of the human cytochromes P450 responsible for atomoxetine metabolism. Drug Metab Dispos. 2002 Mar;30(3):319-23. doi: 10.1124/dmd.30.3.319. (PMID: 11854152)
Sauer JM, Ponsler GD, Mattiuz EL, Long AJ, Witcher JW, Thomasson HR, Desante KA: Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism. Drug Metab Dispos. 2003 Jan;31(1):98-107. doi: 10.1124/dmd.31.1.98. (PMID: 12485958)

>  <Comments>  (11) 


$$$$
CC01900
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4010    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1860    2.0950    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3090    1.7840    0.0300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4070   -0.4150    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170   -0.6880   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3780    1.4020   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1890    3.6020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1260    0.7150    0.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3900    0.0150   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0770    4.1050    1.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6310    0.7800    0.0560 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.1100    1.0450    1.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0740    1.8360   -0.7990 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5780    0.9900    1.5270 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9700    1.2520    2.9190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4650    2.6330    3.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4950    1.2080    3.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3580    0.1860    3.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5  9  2  0
  6 10  1  0
  7 10  2  0
  8 11  1  0
  9 12  1  0
 12 13  1  0
 12 14  1  6
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
M  END
>  <Name>  (12) 
Bufuralol

>  <InChIKey>  (12) 
SSEBTPPFLLCUMN-CYBMUJFWSA-N

>  <PubChem_CID>  (12) 
11276993

>  <CYP1A2>  (12) 
<1,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>
<3,H;Hydroxylation;R3>

>  <CYP2A6>  (12) 


>  <CYP2B6>  (12) 


>  <CYP2C8>  (12) 


>  <CYP2C9>  (12) 


>  <CYP2C19>  (12) 
<1,H;Hydroxylation;R1>

>  <CYP2D6>  (12) 
<1,H;Hydroxylation;R1>

>  <CYP2E1>  (12) 


>  <CYP3A4>  (12) 
<1,H;Hydroxylation;R1>

>  <References>  (12) 
Narimatsu S, Takemi C, Kuramoto S, Tsuzuki D, Hichiya H, Tamagake K, Yamamoto S: Stereoselectivity in the oxidation of bufuralol, a chiral substrate, by human cytochrome P450s. Chirality. 2003 May 5;15(4):333-9. doi: 10.1002/chir.10212. (PMID: 12666241)
Yamazaki H, Guo Z, Persmark M, Mimura M, Inoue K, Guengerich FP, Shimada T: Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Mol Pharmacol. 1994 Sep;46(3):568-77. (PMID: 7935340)

>  <Comments>  (12) 


$$$$
CC01909
     RDKit          3D

 18 18  0  0  0  0  0  0  0  0999 V2000
    0.1140    1.5240    0.0170 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1110   -0.0700    0.0480 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6920    1.8420   -0.0310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5980    2.1420   -1.2880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6270    2.2860    1.5480 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2010   -0.4860    1.3010 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2140    1.1690   -1.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6350    3.5590   -1.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7860   -0.5280    2.2780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4410   -0.8520    1.5800 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7330    1.3420   -1.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1590    4.2220   -2.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4550   -0.9550    3.5540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4130   -0.0510    1.9050 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.7880   -1.2630    2.7850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8590   -1.3260    3.8080 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4320   -1.7320    3.0910 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3280   -1.8680    5.3880 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  1  0
  6  9  2  0
  6 10  1  0
  7 11  1  0
  8 12  1  0
  9 13  1  0
  9 14  1  0
 10 15  2  0
 13 16  2  0
 15 16  1  0
 15 17  1  0
 16 18  1  0
M  END
>  <Name>  (13) 
Chlorpyrifos

>  <InChIKey>  (13) 
SBPBAQFWLVIOKP-UHFFFAOYSA-N

>  <PubChem_CID>  (13) 
2730

>  <CYP1A2>  (13) 
<3,4;Desulfuration;R1>
<3,8;Cleavage;R2>

>  <CYP2A6>  (13) 


>  <CYP2B6>  (13) 
<3,4;Desulfuration;R1>
<3,8;Cleavage;R2>

>  <CYP2C8>  (13) 
<3,4;Desulfuration;R1>
<3,8;Cleavage;R2>

>  <CYP2C9>  (13) 
<3,4;Desulfuration;R1>
<3,8;Cleavage;R2>

>  <CYP2C19>  (13) 
<3,4;Desulfuration;R1>
<3,8;Cleavage;R2>

>  <CYP2D6>  (13) 
<3,4;Desulfuration;R1>
<3,8;Cleavage;R2>

>  <CYP2E1>  (13) 


>  <CYP3A4>  (13) 
<3,4;Desulfuration;R1>
<3,8;Cleavage;R2>

>  <References>  (13) 
Tang J, Cao Y, Rose RL, Brimfield AA, Dai D, Goldstein JA, Hodgson E: Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab Dispos. 2001 Sep;29(9):1201-4. (PMID: 11502728)
Mutch E, Williams FM: Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Toxicology. 2006 Jul 5;224(1-2):22-32. doi: 10.1016/j.tox.2006.04.024. Epub 2006  Apr 26. (PMID: 16757081)

>  <Comments>  (13) 


$$$$
CC01918
     RDKit          3D

 11 12  0  0  0  0  0  0  0  0999 V2000
    1.2980    0.6720    0.0840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1140    1.4020    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0950    0.7190   -0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1080   -0.6730   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0880   -1.3910   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980   -0.7140   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5580   -1.4270   -0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6970   -0.7450    0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7300    0.7170    0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7950    1.3150    0.2970 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5080    1.3820    0.1950 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 11  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
M  END
>  <Name>  (14) 
Coumarin

>  <InChIKey>  (14) 
ZYGHJZDHTFUPRJ-UHFFFAOYSA-N

>  <PubChem_CID>  (14) 
323

>  <CYP1A2>  (14) 
<2,3;EpOxidation;R1>

>  <CYP2A6>  (14) 
<7,H;Hydroxylation;R1>

>  <CYP2B6>  (14) 
<7,H;Hydroxylation;R1>

>  <CYP2C8>  (14) 
<7,H;Hydroxylation;R1>

>  <CYP2C9>  (14) 


>  <CYP2C19>  (14) 


>  <CYP2D6>  (14) 


>  <CYP2E1>  (14) 
<2,3;EpOxidation;R1>

>  <CYP3A4>  (14) 
<2,3;EpOxidation;R1>
<2,H;Hydroxylation;R2>

>  <References>  (14) 
Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ, Korzekwa K: Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biophys. 1991 Oct;290(1):160-6. doi: 10.1016/0003-9861(91)90602-f. (PMID: 1898086)
Lewis DF, Ito Y, Lake BG: Metabolism of coumarin by human P450s: a molecular modelling study. Toxicol In Vitro. 2006 Mar;20(2):256-64. doi: 10.1016/j.tiv.2005.08.001. Epub 2005 Sep 12. (PMID: 16157466)

>  <Comments>  (14) 
More BoMs than Xenosite.

$$$$
CC01927
     RDKit          3D

 10 11  0  0  0  0  0  0  0  0999 V2000
    0.1120    1.2960   -0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2050   -0.0380   -0.4530 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2980   -0.8210    0.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3010   -0.0560    0.9880 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.2040    1.4460    1.0530 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.1120    2.1460    0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0090    2.0060   -1.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3640    0.7960    0.3350 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4410    0.8650   -1.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6850    0.8530    1.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  4  3  1  6
  4  5  1  0
  4  8  1  0
  5  6  1  6
  5  8  1  0
  8  9  1  0
  8 10  1  0
M  END
>  <Name>  (15) 
delta3-carene

>  <InChIKey>  (15) 
BQOFWKZOCNGFEC-BDAKNGLRSA-N

>  <PubChem_CID>  (15) 
443156

>  <CYP1A2>  (15) 
<1,2;EpOxidation;R1>

>  <CYP2A6>  (15) 


>  <CYP2B6>  (15) 
<0,H;Hydroxylation;R1>

>  <CYP2C8>  (15) 


>  <CYP2C9>  (15) 


>  <CYP2C19>  (15) 
<0,H;Hydroxylation;R1>

>  <CYP2D6>  (15) 
<0,H;Hydroxylation;R1>

>  <CYP2E1>  (15) 


>  <CYP3A4>  (15) 


>  <References>  (15) 
Duisken M, Benz D, Peiffer TH, Blomeke B, Hollender J: Metabolism of Delta(3)-carene by human cytochrome p450 enzymes: identification and characterization of two new metabolites. Curr Drug Metab. 2005 Dec;6(6):593-601. (PMID: 16379671)

>  <Comments>  (15) 


$$$$
CC01936
     RDKit          3D

 21 23  0  0  0  0  0  0  0  0999 V2000
    0.1050    1.5550    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0160    0.0620    0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3570    2.3360    0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0690    2.2060   -0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0390   -0.7910    0.3790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2270   -0.5390   -0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3820    1.9120    1.0710 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5600    3.5380   -0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3810    3.6550   -0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3920   -0.2940    0.7730 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8680   -2.1810    0.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3970   -1.9220   -0.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3020    0.7290    1.7600 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5260    2.6850    1.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7080    4.3080   -0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0740    4.0530   -1.3510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3440   -2.7460   -0.0230 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6880    3.8840    0.5990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3970    5.4710   -1.3660 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9570    5.7620   -2.6730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4500    5.7220   -0.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
  6 12  2  0
  7 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
 10 13  1  0
 11 17  2  0
 12 17  1  0
 14 18  2  0
 15 18  1  0
 16 19  1  0
 19 20  1  0
 19 21  1  0
M  END
>  <Name>  (16) 
Doxepin

>  <InChIKey>  (16) 
ODQWQRRAPPTVAG-BOPFTXTBSA-N

>  <PubChem_CID>  (16) 
667468

>  <CYP1A2>  (16) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2A6>  (16) 


>  <CYP2B6>  (16) 


>  <CYP2C8>  (16) 


>  <CYP2C9>  (16) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2C19>  (16) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2D6>  (16) 
<18,H;Hydroxylation;R1>
<9,H;Hydroxylation;R1>

>  <CYP2E1>  (16) 


>  <CYP3A4>  (16) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <References>  (16) 
Hartter S, Tybring G, Friedberg T, Weigmann H, Hiemke C: The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19. Pharm Res. 2002 Jul;19(7):1034-7. (PMID: 12180536)
Haritos VS, Ghabrial H, Ahokas JT, Ching MS: Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin. Pharmacogenetics. 2000 Oct;10(7):591-603. (PMID: 11037801)

>  <Comments>  (16) 


$$$$
CC01945
     RDKit          3D

 42 48  0  0  0  0  0  0  0  0999 V2000
    0.7860    1.3680    0.9400 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.1160    0.0280    0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0770    1.9800    1.4420 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.1640    1.1670    2.0930 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2980   -0.6390    0.5480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1480   -0.5020   -0.5480 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7160    0.9200    2.3960 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.9520    3.1680    2.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1000    0.0080    2.8430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0930    2.1440    2.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3650   -0.1070    1.4880 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.5730   -1.8640   -0.0630 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4120   -1.7200   -1.1520 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6900    1.8450    3.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9170    3.0860    3.2940 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1310    4.0490    2.2510 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9730   -0.1820    3.9050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9680    1.9620    3.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8970   -1.1780    2.2710 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6180   -2.3960   -0.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3360   -2.4530   -2.0080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9110    0.7950    4.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9100   -1.3230    4.6420 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8800    2.9240    3.7620 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3200   -1.1080    2.1540 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.6210   -3.5460   -1.6230 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2450   -3.7740   -1.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7690    0.6130    5.2540 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1400   -2.1170    4.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6910    3.9830    2.8220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7850    0.1050    2.7440 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9460   -2.3130    2.8580 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.1750    0.2100    2.4520 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.4720   -2.2460    2.7170 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.5930   -2.2920    4.2430 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9410   -0.8760    3.2160 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.7110    1.5780    2.8790 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0740   -3.2770    3.5030 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3380   -0.7130    2.9780 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1260    1.6030    2.6730 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6950    0.5750    3.4790 C   0  0  1  0  0  0  0  0  0  0  0  0
    9.1830    0.7180    4.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  1
  4  9  2  0
  4 10  1  0
  5 11  1  0
  5 12  2  0
  6 13  1  0
  7 11  1  0
  7 14  1  1
  8 15  1  0
  8 16  2  0
  9 17  1  0
 10 18  2  0
 11 19  1  1
 12 20  1  0
 13 20  2  0
 13 21  1  0
 14 15  1  0
 17 22  2  0
 17 23  1  0
 18 22  1  0
 18 24  1  0
 25 19  1  1
 20 26  1  0
 21 27  1  0
 22 28  1  0
 23 29  1  0
 24 30  1  0
 25 31  1  0
 25 32  1  0
 26 27  1  0
 31 33  1  0
 32 34  1  0
 32 35  1  1
 33 36  1  0
 33 37  1  1
 34 36  1  0
 34 38  1  1
 36 39  1  6
 37 40  1  0
 39 41  1  0
 40 41  1  0
 41 42  1  1
M  END
>  <Name>  (17) 
Etoposide

>  <InChIKey>  (17) 
VJJPUSNTGOMMGY-PRPOLQJISA-N

>  <PubChem_CID>  (17) 


>  <CYP1A2>  (17) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<38,39;Cleavage;R2>
<39,H;Oxidation;R2>

>  <CYP2A6>  (17) 


>  <CYP2B6>  (17) 


>  <CYP2C8>  (17) 


>  <CYP2C9>  (17) 


>  <CYP2C19>  (17) 


>  <CYP2D6>  (17) 


>  <CYP2E1>  (17) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<38,39;Cleavage;R2>
<39,H;Oxidation;R2>

>  <CYP3A4>  (17) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<38,39;Cleavage;R2>
<39,H;Oxidation;R2>

>  <References>  (17) 
Kawashiro T, Yamashita K, Zhao XJ, Koyama E, Tani M, Chiba K, Ishizaki T: A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes. J Pharmacol Exp Ther. 1998 Sep;286(3):1294-300. (PMID: 9732391)

>  <Comments>  (17) 


$$$$
CC01954
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.1240    1.4920    0.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0470   -0.0260    0.4150 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5650    1.9310    0.2950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3370   -0.4730    0.2090 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5120    1.9500   -0.8230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2210    2.3850    1.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7240    2.4330   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4240    1.6070   -2.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5130    2.6880    1.0420 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8290    2.5640   -1.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5320    1.7450   -2.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7310    2.2230   -2.4620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3950   -1.9240   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1910   -0.0780    1.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3550   -0.0360    2.6190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7820    1.3070    1.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9910   -2.6520    1.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8200   -2.3250   -0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4530    1.4120   -4.3020 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6360    1.5790   -5.0860 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  3  6  2  0
  4 13  1  0
  4 14  1  0
  5  7  2  0
  5  8  1  0
  6  9  1  0
  7  9  1  0
  7 10  1  0
  8 11  2  0
 10 12  2  0
 11 12  1  0
 11 19  1  0
 13 17  1  0
 13 18  1  0
 14 15  1  0
 14 16  1  0
 19 20  1  0
M  END
>  <Name>  (18) 
Foxy

>  <InChIKey>  (18) 
DNBPMBJFRRVTSJ-UHFFFAOYSA-N

>  <PubChem_CID>  (18) 
151182

>  <CYP1A2>  (18) 
<11,15;Cleavage;R1>
<15,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2A6>  (18) 


>  <CYP2B6>  (18) 


>  <CYP2C8>  (18) 
<11,15;Cleavage;R1>
<15,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2C9>  (18) 
<11,15;Cleavage;R1>
<15,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2C19>  (18) 


>  <CYP2D6>  (18) 
<11,15;Cleavage;R1>
<15,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>
<0,1;Cleavage;R3>
<0,H;Oxidation;R3>

>  <CYP2E1>  (18) 


>  <CYP3A4>  (18) 
<11,15;Cleavage;R1>
<15,H;Oxidation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <References>  (18) 
Narimatsu S, Yonemoto R, Saito K, Takaya K, Kumamoto T, Ishikawa T, Asanuma M, Funada M, Kiryu K, Naito S, Yoshida Y, Yamamoto S, Hanioka N: Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes. Biochem Pharmacol. 2006 Apr 28;71(9):1377-85. doi: 10.1016/j.bcp.2006.01.015. Epub 2006 Feb 28. (PMID: 16510126)

>  <Comments>  (18) 
<20,19;Cleavage> is much stronger than <14,4,Cleavage> in CYP2D6.

$$$$
CC01963
     RDKit          3D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -6.2880   -0.1390   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0790    0.2990    0.5010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5460   -1.1250   -1.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8150   -1.2960   -1.6310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8540   -0.4960   -1.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.6190    0.4840   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3360    0.6680    0.2730 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.1040   -0.6780   -1.6500 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8050    1.5190    1.1740 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4190    1.2700    1.2920 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6940   -0.2720    0.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1990   -0.8170    1.6770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7520   -1.2900    1.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8980   -0.1610    1.1420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3160    0.2690   -0.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7390    0.8280   -0.1420 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4670   -0.6900    1.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4150    0.4420    0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8360   -0.1080    0.4700 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7220    0.9490    0.0960 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9600    0.4030   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1440   -0.9520    0.2340 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3970   -1.5110    0.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4910   -0.7140   -0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3050    0.6530   -0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0440    1.2040   -0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8290   -1.3080   -0.3480 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8590    2.5290   -0.6180 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1370    3.0680   -0.9600 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7750   -0.6150   -0.6580 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0270   -2.7780   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2 10  2  0
  2 11  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  8  1  0
  6  7  2  0
  7  9  1  0
  9 10  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 17  1  0
 15 16  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 26  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 27  1  0
 25 26  2  0
 26 28  1  0
 27 30  2  0
 27 31  1  0
 28 29  1  0
M  END
>  <Name>  (19) 
Iloperidone

>  <InChIKey>  (19) 
XMXHEBAFVSFQEX-UHFFFAOYSA-N

>  <PubChem_CID>  (19) 
71360

>  <CYP1A2>  (19) 
<5,7;Dehydrogenation;R1>

>  <CYP2A6>  (19) 


>  <CYP2B6>  (19) 


>  <CYP2C8>  (19) 


>  <CYP2C9>  (19) 


>  <CYP2C19>  (19) 


>  <CYP2D6>  (19) 
<6,H;Hydroxylation;R1>

>  <CYP2E1>  (19) 
<5,7;Dehydrogenation;R1>

>  <CYP3A4>  (19) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<5,7;Dehydrogenation;R2>

>  <References>  (19) 
Mutlib AE, Klein JT: Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome P450 isoforms involved in the metabolism of iloperidone. J Pharmacol Exp Ther. 1998 Sep;286(3):1285-93. (PMID: 9732390)

>  <Comments>  (19) 


$$$$
CC01972
     RDKit          3D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -2.8000    3.7890    0.4670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2190    4.6740   -0.4190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1880    4.2350   -1.2300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7800    2.9900   -1.1570 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3220    2.0980   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3390    2.4680    0.5380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0290    1.6270    1.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3540    0.3210    1.8980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4090   -0.6610    0.7680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6510   -0.4610   -0.3590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6980   -1.3510   -1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5190   -2.4600   -1.3400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2790   -2.6700   -0.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2290   -1.7750    0.8540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7760    0.7250   -0.3930 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5480    0.5510   -0.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4860    1.7380   -0.5030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5430    1.5430    0.5910 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1070    0.1920    0.4680 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2100   -0.9690    0.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1440   -0.8380   -0.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4310    0.0200    0.2900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9400   -1.2220    0.1780 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3670   -1.4070   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6790   -2.9020   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1670    0.9850    0.2310 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3030   -4.0670   -0.0950 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5 15  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 14  1  0
 10 11  1  0
 10 15  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 27  1  0
 15 16  2  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 22  1  0
 20 21  1  0
 22 23  1  0
 22 26  2  0
 23 24  1  0
 24 25  1  0
M  END
>  <Name>  (20) 
Loratadine

>  <InChIKey>  (20) 
JCCNYMKQOSZNPW-UHFFFAOYSA-N

>  <PubChem_CID>  (20) 
3957

>  <CYP1A2>  (20) 
<1,H;Hydroxylation;R1>

>  <CYP2A6>  (20) 


>  <CYP2B6>  (20) 
<1,H;Hydroxylation;R1>

>  <CYP2C8>  (20) 
<1,H;Hydroxylation;R1>

>  <CYP2C9>  (20) 
<1,H;Hydroxylation;R1>

>  <CYP2C19>  (20) 
<1,H;Hydroxylation;R1>

>  <CYP2D6>  (20) 
<1,H;Hydroxylation;R1>

>  <CYP2E1>  (20) 


>  <CYP3A4>  (20) 
<1,H;Hydroxylation;R1>

>  <References>  (20) 
Ghosal A, Gupta S, Ramanathan R, Yuan Y, Lu X, Su AD, Alvarez N, Zbaida S, Chowdhury SK, Alton KB: Metabolism of loratadine and further characterization of its in vitro metabolites. Drug Metab Lett. 2009 Aug;3(3):162-70. Epub 2009 Aug 1. (PMID: 19702548)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)

>  <Comments>  (20) 
The original reference is not accessible. Followed Xenosite and consider the second reference.

$$$$
CC01981
     RDKit          3D

 26 29  0  0  0  0  0  0  0  0999 V2000
   -0.8940    0.8200    0.4900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0400   -0.5430    0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5790   -1.0300    1.0710 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2330    1.4390    1.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0060   -1.4680    0.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3970    0.7160    1.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0310    1.6810    0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0500    3.5390   -2.9490 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2400   -1.0280   -0.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9440    2.1960   -1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1200    3.0890   -1.5630 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.1870   -2.8180    0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4240   -2.3710   -0.6890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9660   -2.9330   -1.4070 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8920   -1.7530   -1.3570 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3870   -3.2700   -0.4750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0910    2.3780   -3.8270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2470    4.3090   -3.2550 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2280    2.8140    1.3500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5010    1.3640    1.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1730    4.2640   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4260   -4.0370   -0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3680    5.5470   -2.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3260    3.4560    1.9160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4690    2.7260    2.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2800    5.2430   -0.9170 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  1  7  1  0
  2  5  2  0
  2  9  1  0
  3  5  1  0
  3  6  1  0
  4  6  2  0
  4 19  1  0
  5 12  1  0
  6 20  1  0
  7 10  1  0
  8 11  1  0
  8 17  1  0
  8 18  1  0
  9 13  2  0
 11 10  1  1
 11 21  1  0
 12 16  2  0
 13 14  1  0
 13 16  1  0
 14 15  2  0
 14 22  1  1
 18 23  1  0
 19 24  2  0
 20 25  2  0
 21 26  1  0
 23 26  1  0
 24 25  1  0
M  END
>  <Name>  (21) 
Mesoridazine

>  <InChIKey>  (21) 
SLVMESMUVMCQIY-AKJBCIBTSA-N

>  <PubChem_CID>  (21) 
57146948

>  <CYP1A2>  (21) 


>  <CYP2A6>  (21) 


>  <CYP2B6>  (21) 


>  <CYP2C8>  (21) 


>  <CYP2C9>  (21) 


>  <CYP2C19>  (21) 


>  <CYP2D6>  (21) 
<21,S;S-Oxidation;R1>

>  <CYP2E1>  (21) 


>  <CYP3A4>  (21) 


>  <References>  (21) 
Wojcikowski J, Maurel P, Daniel WA: Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine. Drug Metab Dispos. 2006 Mar;34(3):471-6. doi: 10.1124/dmd.105.006445. Epub 2005 Nov 4. (PMID: 16272405)

>  <Comments>  (21) 


$$$$
CC01990
     RDKit          3D

 29 32  0  0  0  0  0  0  0  0999 V2000
    4.9490    5.6840    1.3110 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.0260    2.2230   -0.9340 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.1950   -1.7210   -0.5560 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2050    4.3490    0.7430 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4570    3.0210    1.0120 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2810   -1.9440    0.6450 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2080   -3.1710   -0.4950 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.8260   -3.6910   -0.2570 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5830    2.2770    0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5150    0.8370    0.6950 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7010    3.0800    0.5370 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3300   -1.1640    0.0750 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8040   -3.7250   -1.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4200    0.2250    0.0890 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0910    2.8450    0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8600   -3.7280   -1.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4900   -4.1380    1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4870    0.0470    1.2940 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8760    4.2620    1.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3260   -1.3250    1.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4530    1.7310   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0880    3.7520    0.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5800   -4.2110   -1.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2110   -4.6210    1.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2570   -4.6580    0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7780    1.5150   -0.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4170    3.5470    0.1710 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7500    2.4260   -0.5810 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3330    4.9290    1.5950 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 19  1  0
  1 29  1  0
  2 28  1  0
  3  7  1  0
  3 12  1  0
  4 11  1  0
  4 19  1  0
  5  9  1  0
  5 19  2  0
  6 12  2  0
  6 20  1  0
  7  8  1  0
  7 13  1  6
  8 16  2  0
  8 17  1  0
  9 10  1  0
  9 11  2  0
 10 14  2  0
 10 18  1  0
 11 15  1  0
 12 14  1  0
 15 21  2  0
 15 22  1  0
 16 23  1  0
 17 24  2  0
 18 20  2  0
 21 26  1  0
 22 27  2  0
 23 25  2  0
 24 25  1  0
 26 28  2  0
 27 28  1  0
M  END
>  <Name>  (22) 
ML-3403

>  <InChIKey>  (22) 
VXPWQNBKEIVYIS-OAHLLOKOSA-N

>  <PubChem_CID>  (22) 
10862355

>  <CYP1A2>  (22) 
<1,S;Oxidation;R1>

>  <CYP2A6>  (22) 


>  <CYP2B6>  (22) 


>  <CYP2C8>  (22) 
<1,S;Oxidation;R1>

>  <CYP2C9>  (22) 
<1,S;Oxidation;R1>

>  <CYP2C19>  (22) 
<1,S;Oxidation;R1>

>  <CYP2D6>  (22) 
<1,S;Oxidation;R1>

>  <CYP2E1>  (22) 


>  <CYP3A4>  (22) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>
<1,S;Oxidation;R2>
<8,N;Oxidation;R3>

>  <References>  (22) 
Kammerer B, Scheible H, Albrecht W, Gleiter CH, Laufer S: Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-pheny lethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor. Drug Metab Dispos. 2007 Jun;35(6):875-83. doi: 10.1124/dmd.106.013409. Epub 2007  Mar 7. (PMID: 17344341)

>  <Comments>  (22) 


$$$$
CC01999
     RDKit          3D

 19 21  0  0  0  0  0  0  0  0999 V2000
    1.6670   -2.6700    0.3180 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3360   -1.4640    0.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7350   -0.2460    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4160   -0.2350   -0.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2440   -1.4520   -0.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3850   -2.6560   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4480   -4.1320   -0.4700 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.3790    1.0180   -0.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5400    0.8850    0.3670 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0440    3.1120    0.1140 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3980    2.1200   -0.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4720    2.1300   -1.4080 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0930    2.1200   -0.9530 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8100    1.0380   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2660    0.2310    0.9930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6890    1.9220   -0.6790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5990    0.2920    1.3910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0220    1.9820   -0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4760    1.1660    0.7540 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  9  1  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  6  7  1  0
  8 13  2  0
  8 14  1  0
  9 11  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 14 15  2  0
 14 16  1  0
 15 17  1  0
 16 18  2  0
 17 19  2  0
 18 19  1  0
M  END
>  <Name>  (23) 
Nordiazepam

>  <InChIKey>  (23) 
AKPLHCDWDRPJGD-UHFFFAOYSA-N

>  <PubChem_CID>  (23) 
2997

>  <CYP1A2>  (23) 
<2,H;Hydroxylation;R1>

>  <CYP2A6>  (23) 


>  <CYP2B6>  (23) 


>  <CYP2C8>  (23) 


>  <CYP2C9>  (23) 


>  <CYP2C19>  (23) 
<2,H;Hydroxylation;R1>

>  <CYP2D6>  (23) 


>  <CYP2E1>  (23) 


>  <CYP3A4>  (23) 
<2,H;Hydroxylation;R1>

>  <References>  (23) 
Yang TJ, Shou M, Korzekwa KR, Gonzalez FJ, Gelboin HV, Yang SK: Role of cDNA-expressed human cytochromes P450 in the metabolism of diazepam. Biochem Pharmacol. 1998 Mar 15;55(6):889-96. doi: 10.1016/s0006-2952(97)00558-3. (PMID: 9586962)
Ono S, Hatanaka T, Miyazawa S, Tsutsui M, Aoyama T, Gonzalez FJ, Satoh T: Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Xenobiotica. 1996 Nov;26(11):1155-66. doi: 10.3109/00498259609050260. (PMID: 8948091)

>  <Comments>  (23) 


$$$$
CC02008
     RDKit          3D

 23 27  0  0  0  0  0  0  0  0999 V2000
   -0.2940    1.5470   -0.1680 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.5160    0.0620   -0.3270 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2090    1.7270   -0.0160 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.1640    1.8480    1.0420 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7710    2.2670   -1.4280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6920   -0.2610    0.3330 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3400   -0.8350   -0.9230 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8700    1.1380   -1.2620 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.7020    1.0060    1.2370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5160    3.1200    0.0760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2070    0.8330    0.9350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4410    1.6050    2.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0070    1.6840   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1160   -1.5940    0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6560   -0.3550   -1.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0940   -2.1490   -0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4340    1.8770   -2.4490 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0510    1.6530    2.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0940    1.3580    3.3200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2960   -2.5020   -0.3670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2750   -1.9870    0.8920 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0870    1.2470   -3.6040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3980   -3.3930    0.6690 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  6
  2  6  2  0
  2  7  1  0
  3  8  1  0
  3  9  1  0
  3 10  1  1
  4 11  1  1
  4 12  1  0
  5 13  1  0
  6 11  1  0
  6 14  1  0
  7 15  1  0
  7 16  2  0
  8 15  1  6
  8 17  1  0
  9 18  1  0
 12 18  1  0
 12 19  2  0
 13 17  1  0
 14 20  2  0
 14 21  1  0
 16 20  1  0
 17 22  1  0
 21 23  1  0
M  END
>  <Name>  (24) 
Oxycodone

>  <InChIKey>  (24) 
BRUQQQPBMZOVGD-XFKAJCMBSA-N

>  <PubChem_CID>  (24) 
5284603

>  <CYP1A2>  (24) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2A6>  (24) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2B6>  (24) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2C8>  (24) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2C9>  (24) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2C19>  (24) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2D6>  (24) 
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2E1>  (24) 


>  <CYP3A4>  (24) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>

>  <References>  (24) 
Lalovic B, Phillips B, Risler LL, Howald W, Shen DD: Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes. Drug Metab Dispos. 2004 Apr;32(4):447-54. doi: 10.1124/dmd.32.4.447. (PMID: 15039299)

>  <Comments>  (24) 


$$$$
CC02017
     RDKit          2D

 14 16  0  0  0  0  0  0  0  0999 V2000
    1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6890    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4600    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    3.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    2.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4600    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 10  1  0
  2  3  1  0
  2 11  1  0
  3  4  2  0
  3 14  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
M  END
>  <Name>  (25) 
Phenanthrene

>  <InChIKey>  (25) 
YNPNZTXNASCQKK-UHFFFAOYSA-N

>  <PubChem_CID>  (25) 
995

>  <CYP1A2>  (25) 
<1,2;EpOxidation;R1>
<11,12;EpOxidation;R2>
<6,7;EpOxidation;R3>
<5,0;EpOxidation;R4>
<9,10;EpOxidation;R5>
<0,H;Hydroxylation;R6>
<10,H;Hydroxylation;R7>
<3,H;Hydroxylation;R8>
<1,H;Hydroxylation;R9>
<6,H;Hydroxylation;R10>
<7,H;Hydroxylation;R11>
<12,H;Hydroxylation;R12>
<11,H;Hydroxylation;R13>
<9,H;Hydroxylation;R14>
<2,H;Hydroxylation;R15>

>  <CYP2A6>  (25) 


>  <CYP2B6>  (25) 


>  <CYP2C8>  (25) 


>  <CYP2C9>  (25) 


>  <CYP2C19>  (25) 


>  <CYP2D6>  (25) 


>  <CYP2E1>  (25) 


>  <CYP3A4>  (25) 


>  <References>  (25) 
Shou M, Korzekwa KR, Krausz KW, Crespi CL, Gonzalez FJ, Gelboin HV: Regio- and stereo-selective metabolism of phenanthrene by twelve cDNA-expressed human, rodent, and rabbit cytochromes P-450. Cancer Lett. 1994 Aug 15;83(1-2):305-13. (PMID: 8062229)

>  <Comments>  (25) 
Metabolites under 0.1 are not considered.

$$$$
CC02026
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
    0.0180    1.3640   -0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1300   -0.0370   -0.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0330   -0.7640   -0.1380 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9540   -5.2220   -0.3830 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1950    2.1450    0.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0770   -2.9390   -0.1940 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7780   -2.1630   -0.2100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7540   -4.4180   -0.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8110   -2.6060    0.9760 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5960   -6.6300   -0.3530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5470    0.1450   -0.0340 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3940   -0.6330   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2200    2.0240    0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4450    1.5300    0.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1120    3.5350    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0780   -7.0300    1.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8340   -7.4330   -0.6670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2950    3.4130    0.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1280    4.1680    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  5  1  0
  1 13  1  0
  2  3  1  0
  2 12  1  0
  3  7  1  0
  4  8  1  0
  4 10  1  0
  5 14  2  0
  5 15  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  1
 10 16  1  0
 10 17  1  0
 11 12  2  0
 11 14  1  0
 13 18  2  0
 15 19  2  0
 18 19  1  0
M  END
>  <Name>  (26) 
Propranolol

>  <InChIKey>  (26) 
AQHHHDLHHXJYJD-CQSZACIVSA-N

>  <PubChem_CID>  (26) 
21138

>  <CYP1A2>  (26) 
<1,3;Cleavage;R1>
<1,H;Oxidation;R1>
<14,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2A6>  (26) 


>  <CYP2B6>  (26) 


>  <CYP2C8>  (26) 


>  <CYP2C9>  (26) 


>  <CYP2C19>  (26) 


>  <CYP2D6>  (26) 
<1,3;Cleavage;R1>
<1,H;Oxidation;R1>
<14,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2E1>  (26) 


>  <CYP3A4>  (26) 


>  <References>  (26) 
Rowland K, Ellis SW, Lennard MS, Tucker GT: Variable contribution of CYP2D6 to the N-dealkylation of S-(-)-propranolol by human liver microsomes. Br J Clin Pharmacol. 1996 Sep;42(3):390-3. doi: 10.1046/j.1365-2125.1996.43116.x. (PMID: 8877032)
Ching MS, Bichara N, Blake CL, Ghabrial H, Tukey RH, Smallwood RA: Propranolol 4- and 5-hydroxylation and N-desisopropylation by cloned human cytochrome P4501A1 and P4501A2. Drug Metab Dispos. 1996 Jun;24(6):692-4. (PMID: 8781788)
Mankowski DC: The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6. Drug Metab Dispos. 1999 Sep;27(9):1024-8. (PMID: 10460802)
Yoshimoto K, Echizen H, Chiba K, Tani M, Ishizaki T: Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2. Br J Clin Pharmacol. 1995 Apr;39(4):421-31. doi: 10.1111/j.1365-2125.1995.tb04472.x. (PMID: 7640150)

>  <Comments>  (26) 


$$$$
CC02035
     RDKit          3D

 19 20  0  0  0  0  0  0  0  0999 V2000
    1.0890    0.8930    0.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1910    0.4080    0.9460 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1680    0.0460    0.2090 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3570    0.4770   -0.3680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4420    1.7850   -0.8390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3590    2.6330   -0.7290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1800    2.1900   -0.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3890   -1.3940    0.6120 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2970   -0.5550   -0.3640 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0920   -0.1970   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3400   -0.6700    0.4810 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0280    0.5160    1.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1750   -1.1920   -0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2290    1.5320   -0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8870    2.7940    0.4440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4470   -1.8100   -0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3170   -2.3530   -1.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8150   -1.6800    0.1900 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4100   -2.7280    0.3260 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2 10  1  0
  3  4  1  0
  3  8  1  0
  4  5  2  0
  4  9  1  0
  5  6  1  0
  6  7  2  0
  8 18  1  0
  9 18  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 12 14  1  0
 13 16  1  0
 14 15  1  0
 16 17  1  0
 18 19  2  0
M  END
>  <Name>  (27) 
Ropinirole

>  <InChIKey>  (27) 
UHSKFQJFRQCDBE-UHFFFAOYSA-N

>  <PubChem_CID>  (27) 
5095

>  <CYP1A2>  (27) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>
<10,12;Cleavage;R2>
<12,H;Oxidation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2A6>  (27) 


>  <CYP2B6>  (27) 


>  <CYP2C8>  (27) 


>  <CYP2C9>  (27) 


>  <CYP2C19>  (27) 


>  <CYP2D6>  (27) 


>  <CYP2E1>  (27) 


>  <CYP3A4>  (27) 
<10,11;Cleavage;R1>
<11,H;Oxidation;R1>
<10,12;Cleavage;R2>
<12,H;Oxidation;R2>
<12,H;Hydroxylation;R3>

>  <References>  (27) 
Bloomer JC, Clarke SE, Chenery RJ: In vitro identification of the P450 enzymes responsible for the metabolism of ropinirole. Drug Metab Dispos. 1997 Jul;25(7):840-4. (PMID: 9224778)

>  <Comments>  (27) 


$$$$
CC02044
     RDKit          3D

 28 30  0  0  0  0  0  0  0  0999 V2000
   -0.0590    1.3520   -0.1040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0030    0.0160    0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1860    2.1280   -0.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3710    2.0320   -0.1640 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2950   -0.6820    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2520   -0.7520    0.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4490    2.7380   -1.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0980    2.2570    0.7530 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7380    2.9370    0.8340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2460    1.7760   -1.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8400   -1.2710    1.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9820   -0.7670   -1.1660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4100   -0.8560    1.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6100    3.4600   -1.6980 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2570    2.9810    0.5710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9630    3.5680    0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4680    2.4140   -1.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0520   -1.9240    1.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1930   -1.4250   -1.2250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5180    3.5820   -0.6540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8280    3.3050   -0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7290   -1.9990   -0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6610    4.2940   -0.8300 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3780    4.2360    0.4050 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6840    5.0230    0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3790    6.4450    0.0670 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9790    6.9850    1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6450    7.1000   -0.2910 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  4 10  1  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  7 14  1  0
  8 15  2  0
  9 16  1  0
 10 17  2  0
 11 18  1  0
 12 19  2  0
 14 20  2  0
 15 20  1  0
 16 21  2  0
 17 21  1  0
 18 22  2  0
 19 22  1  0
 20 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
M  END
>  <Name>  (28) 
Tamoxifen

>  <InChIKey>  (28) 
NKANXQFJJICGDU-QPLCGJKRSA-N

>  <PubChem_CID>  (28) 
2733526

>  <CYP1A2>  (28) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<17,19;Cleavage;R2>
<19,H;Oxidation;R2>

>  <CYP2A6>  (28) 


>  <CYP2B6>  (28) 
<7,H;Hydroxylation;R1>
<25,H;Hydroxylation;R2>

>  <CYP2C8>  (28) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<17,19;Cleavage;R2>
<19,H;Oxidation;R2>

>  <CYP2C9>  (28) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<17,19;Cleavage;R2>
<19,H;Oxidation;R2>

>  <CYP2C19>  (28) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<17,19;Cleavage;R2>
<19,H;Oxidation;R2>
<7,H;Hydroxylation;R3>

>  <CYP2D6>  (28) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<17,19;Cleavage;R2>
<19,H;Oxidation;R2>
<7,H;Hydroxylation;R3>
<25,H;Hydroxylation;R4>
<1,H;Hydroxylation;R5>

>  <CYP2E1>  (28) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<17,19;Cleavage;R2>
<19,H;Oxidation;R2>
<7,H;Hydroxylation;R3>

>  <CYP3A4>  (28) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>
<17,19;Cleavage;R2>
<19,H;Oxidation;R2>
<7,H;Hydroxylation;R3>
<25,H;Hydroxylation;R4>
<1,H;Hydroxylation;R5>

>  <References>  (28) 
Desta Z, Ward BA, Soukhova NV, Flockhart DA: Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther. 2004 Sep;310(3):1062-75. doi: 10.1124/jpet.104.065607. Epub 2004 May 24. (PMID: 15159443)
Crewe HK, Notley LM, Wunsch RM, Lennard MS, Gillam EM: Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. Drug Metab Dispos. 2002 Aug;30(8):869-74. doi: 10.1124/dmd.30.8.869. (PMID: 12124303)
Styles JA, Davies A, Lim CK, De Matteis F, Stanley LA, White IN, Yuan ZX, Smith LL: Genotoxicity of tamoxifen, tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450s. Carcinogenesis. 1994 Jan;15(1):5-9. doi: 10.1093/carcin/15.1.5. (PMID: 8293548)

>  <Comments>  (28) 


$$$$
CC02053
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -5.9060    0.0420   -1.1980 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5800   -2.3050    0.9880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6740    1.5130   -2.6250 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8900   -0.6890   -0.5560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2100   -1.1150   -0.1220 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5200    1.0760   -2.2370 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6470    0.5240   -1.6850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3170    0.2750   -1.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7090   -0.1610   -1.0220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8580   -1.4310    0.1610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3690    1.8120   -2.9250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4690   -0.9290   -0.3460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8360    2.1400   -3.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  2  0
  2 10  2  0
  3  7  1  0
  3 11  1  0
  3 13  1  0
  4  8  1  0
  4 10  1  0
  4 12  1  0
  5  9  1  0
  5 10  1  0
  6  8  1  0
  6 11  2  0
  7  8  2  0
  7  9  1  0
M  END
>  <Name>  (29) 
Theobromine

>  <InChIKey>  (29) 
YAPQBXQYLJRXSA-UHFFFAOYSA-N

>  <PubChem_CID>  (29) 
5429

>  <CYP1A2>  (29) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>

>  <CYP2A6>  (29) 


>  <CYP2B6>  (29) 


>  <CYP2C8>  (29) 


>  <CYP2C9>  (29) 


>  <CYP2C19>  (29) 


>  <CYP2D6>  (29) 


>  <CYP2E1>  (29) 
<11,12;Cleavage;R1>
<12,H;Oxidation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>
<2,H;Hydroxylation;R3>

>  <CYP3A4>  (29) 


>  <References>  (29) 
Gates S, Miners JO: Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism. Br J Clin Pharmacol. 1999 Mar;47(3):299-305. doi: 10.1046/j.1365-2125.1999.00890.x. (PMID: 10215755)

>  <Comments>  (29) 


$$$$
CC02062
     RDKit          3D

 19 21  0  0  0  0  0  0  0  0999 V2000
    0.8460   -0.6200   -6.2970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2670    0.1450   -5.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5320    0.4460   -4.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3070   -0.0210   -3.5960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4340   -0.7790   -3.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6990   -1.0800   -5.2960 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0150    0.2990   -2.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1030    1.6220   -1.9210 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3470    1.9720   -0.6290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4790    1.0300    0.3880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3730   -0.2710    0.0950 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1380   -0.6520   -1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0870   -2.0130   -1.3930 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7130    1.3680    1.6540 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8260    2.6630    1.9510 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7190    3.6470    1.0590 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4810    3.2910   -0.2140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3700    4.3250   -1.1300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0680    3.0030    3.2540 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  2  0
  9 17  1  0
 10 11  1  0
 10 14  1  0
 11 12  2  0
 12 13  1  0
 14 15  2  0
 15 16  1  0
 15 19  1  0
 16 17  2  0
 17 18  1  0
M  END
>  <Name>  (30) 
Triamterene

>  <InChIKey>  (30) 
FNYLWPVRPXGIIP-UHFFFAOYSA-N

>  <PubChem_CID>  (30) 
5546

>  <CYP1A2>  (30) 
<11,H;Hydroxylation;R1>

>  <CYP2A6>  (30) 


>  <CYP2B6>  (30) 


>  <CYP2C8>  (30) 


>  <CYP2C9>  (30) 


>  <CYP2C19>  (30) 


>  <CYP2D6>  (30) 


>  <CYP2E1>  (30) 


>  <CYP3A4>  (30) 


>  <References>  (30) 
Fuhr U, Kober S, Zaigler M, Mutschler E, Spahn-Langguth H: Rate-limiting biotransformation of triamterene is mediated by CYP1A2. Int J Clin Pharmacol Ther. 2005 Jul;43(7):327-34. doi: 10.5414/cpp43327. (PMID: 16035375)

>  <Comments>  (30) 


$$$$
CC02071
     RDKit          3D

 22 24  0  0  0  0  0  0  0  0999 V2000
    0.3360    1.9550   -0.3970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4180    0.5680   -0.6020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4970    2.8440   -0.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9350    2.5460   -0.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9420   -0.3530   -0.6610 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7550   -0.1860   -0.7370 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6110    2.8100   -0.9440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3280    3.8820    0.6920 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0900    1.7860   -0.4850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8010    0.5030   -1.9670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0080    0.4160   -0.6830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0330    1.8850   -1.9790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230    3.3140    1.9980 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6250    2.5460   -0.4110 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.3080   -0.2880   -3.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7900    2.4390   -3.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7350    4.2160    3.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0410    0.2780   -4.0430 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2850    1.6450   -4.0470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7180    4.1450    2.9580 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1410    2.8340    3.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2230    5.1130    3.9140 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  1  0
  3  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  6 11  2  0
  7 12  1  0
  8 13  1  0
  9 11  1  0
  9 14  1  0
 10 12  2  0
 10 15  1  0
 12 16  1  0
 13 17  1  0
 15 18  2  0
 16 19  2  0
 17 20  1  0
 18 19  1  0
 20 21  1  0
 20 22  1  0
M  END
>  <Name>  (31) 
Zotepine

>  <InChIKey>  (31) 
HDOZVRUNCMBHFH-UHFFFAOYSA-N

>  <PubChem_CID>  (31) 
5736

>  <CYP1A2>  (31) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<10,H;Hydroxylation;R3>
<11,H;Hydroxylation;R4>
<14,S;S-Oxidation;R5>

>  <CYP2A6>  (31) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2B6>  (31) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<11,H;Hydroxylation;R3>
<14,S;S-Oxidation;R4>

>  <CYP2C8>  (31) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<14,S;S-Oxidation;R3>

>  <CYP2C9>  (31) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<14,S;S-Oxidation;R3>

>  <CYP2C19>  (31) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<10,H;Hydroxylation;R3>
<11,H;Hydroxylation;R4>
<14,S;S-Oxidation;R5>

>  <CYP2D6>  (31) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP2E1>  (31) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>

>  <CYP3A4>  (31) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidation;R2>
<11,H;Hydroxylation;R3>
<14,S;S-Oxidation;R4>

>  <References>  (31) 
Shiraga T, Kaneko H, Iwasaki K, Tozuka Z, Suzuki A, Hata T: Identification of cytochrome P450 enzymes involved in the metabolism of zotepine, an antipsychotic drug, in human liver microsomes. Xenobiotica. 1999 Mar;29(3):217-29. doi: 10.1080/004982599238623. (PMID: 10219963)

>  <Comments>  (31) 


$$$$
CC02080
     RDKit          3D

 16 18  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4600   -0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1770    2.1810    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2650    2.1200    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2350   -0.6950   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2180   -0.6990   -0.0150 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    1.5080   -0.0010 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4100    1.3890    0.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4390    0.0450   -0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3880   -0.0040   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6200    2.2180    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6860   -0.6010   -0.0110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7940    1.5330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8280    0.1400   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2630   -2.1100   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2290   -2.7390    0.0780 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  4  8  2  0
  5  9  1  0
  5 15  1  0
  6 10  2  0
  7  9  2  0
  7 11  1  0
  8 10  1  0
  9 12  1  0
 11 13  2  0
 12 14  2  0
 13 14  1  0
 15 16  2  0
M  END
>  <Name>  (32) 
9-Anthraldehyde

>  <InChIKey>  (32) 
YMNKUHIVVMFOFO-UHFFFAOYSA-N

>  <PubChem_CID>  (32) 
69504

>  <CYP1A2>  (32) 


>  <CYP2A6>  (32) 
<1,H;Hydroxylation;R1>

>  <CYP2B6>  (32) 
<1,H;Hydroxylation;R1>

>  <CYP2C8>  (32) 


>  <CYP2C9>  (32) 


>  <CYP2C19>  (32) 
<1,H;Hydroxylation;R1>

>  <CYP2D6>  (32) 


>  <CYP2E1>  (32) 
<1,H;Hydroxylation;R1>

>  <CYP3A4>  (32) 
<1,H;Hydroxylation;R1>

>  <References>  (32) 
Watanabe K, Matsunaga T, Kimura T, Funahashi T, Funae Y, Ohshima T, Yamamoto I: Major cytochrome P450 enzymes responsible for microsomal aldehyde oxygenation of 11-oxo-Delta8-tetrahydrocannabinol and 9-anthraldehyde in human liver. Drug Metab Pharmacokinet. 2002;17(6):516-21. (PMID: 15618706)

>  <Comments>  (32) 


$$$$
CC02089
     RDKit          3D

  6  5  0  0  0  0  0  0  0  0999 V2000
   -1.3300    2.1530    0.6200 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4160    1.6620    0.9520 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4410    3.4330    0.3750 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3870    3.7480   -0.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1580    4.0560    0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4000    3.7680   -1.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
M  END
>  <Name>  (33) 
NMEA

>  <InChIKey>  (33) 
RTDCJKARQCRONF-UHFFFAOYSA-N

>  <PubChem_CID>  (33) 
25418

>  <CYP1A2>  (33) 


>  <CYP2A6>  (33) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP2B6>  (33) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP2C8>  (33) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP2C9>  (33) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP2C19>  (33) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP2D6>  (33) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP2E1>  (33) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <CYP3A4>  (33) 
<2,3;Cleavage;R1>
<3,H;Oxidation;R1>
<1,2;Cleavage;R2>
<1,H;Oxidation;R2>

>  <References>  (33) 
Bellec G, Dreano Y, Lozach P, Menez JF, Berthou F: Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes. Carcinogenesis. 1996 Sep;17(9):2029-34. doi: 10.1093/carcin/17.9.2029. (PMID: 8824531)

>  <Comments>  (33) 


$$$$
CC02098
     RDKit          2D

  5  5  0  0  0  0  0  0  0  0999 V2000
   -0.5450    0.4820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5300    0.2860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1150   -0.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9690    0.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9920   -0.7500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  3  4  1  0
  3  5  1  0
  4  5  1  0
M  END
>  <Name>  (34) 
Butadiene monoxide

>  <InChIKey>  (34) 
GXBYFVGCMPJVJX-UHFFFAOYSA-N

>  <PubChem_CID>  (34) 
13586

>  <CYP1A2>  (34) 


>  <CYP2A6>  (34) 
<0,1;Epoxidation;R1>

>  <CYP2B6>  (34) 


>  <CYP2C8>  (34) 


>  <CYP2C9>  (34) 
<0,1;Epoxidation;R1>

>  <CYP2C19>  (34) 


>  <CYP2D6>  (34) 


>  <CYP2E1>  (34) 
<0,1;Epoxidation;R1>

>  <CYP3A4>  (34) 


>  <References>  (34) 
Krause RJ, Elfarra AA: Oxidation of butadiene monoxide to meso- and (+/-)-diepoxybutane by cDNA-expressed human cytochrome P450s and by mouse, rat, and human liver microsomes: evidence for preferential hydration of meso-diepoxybutane in rat and human liver microsomes. Arch Biochem Biophys. 1997 Jan 15;337(2):176-84. doi: 10.1006/abbi.1996.9781. (PMID: 9016811)

>  <Comments>  (34) 


$$$$
CC02107
     RDKit          3D

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.0210    1.6800    0.0110 P   0  0  1  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4930    2.2300    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7340    2.1720   -1.1880 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8060    2.2240    1.3970 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3810   -0.4440   -0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7910    3.6920    1.3420 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7710   -0.4020   -1.1850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3790   -2.1970    0.3810 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -2.1550    6.0320    1.6430 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.1790    0.1870   -1.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1130    1.7110   -1.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6810   -1.6580    0.6580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1740    4.2310    1.7110 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  1  5  1  1
  2  6  1  0
  2  8  1  0
  3 12  1  0
  5  7  1  0
  6 13  1  0
  7 14  1  0
  8 11  1  0
  9 13  1  0
 10 14  1  0
 11 12  1  0
M  END
>  <Name>  (35) 
Ifosfamide

>  <InChIKey>  (35) 
HOMGKSMUEGBAAB-CQSZACIVSA-N

>  <PubChem_CID>  (35) 
9588020

>  <CYP1A2>  (35) 


>  <CYP2A6>  (35) 
<9,H;Hydroxylation;R1>

>  <CYP2B6>  (35) 
<9,H;Hydroxylation;R1>
<10,11;Cleavage;R2>
<11,H;Oxidation;R2>
<2,3;Cleavage;R3>
<3,H;Oxidation;R3>

>  <CYP2C8>  (35) 
<9,H;Hydroxylation;R1>

>  <CYP2C9>  (35) 
<9,H;Hydroxylation;R1>

>  <CYP2C19>  (35) 
<9,H;Hydroxylation;R1>

>  <CYP2D6>  (35) 


>  <CYP2E1>  (35) 


>  <CYP3A4>  (35) 
<9,H;Hydroxylation;R1>
<10,11;Cleavage;R2>
<11,H;Oxidation;R2>
<2,3;Cleavage;R3>
<3,H;Oxidation;R3>

>  <References>  (35) 
Roy P, Yu LJ, Crespi CL, Waxman DJ: Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug Metab Dispos. 1999 Jun;27(6):655-66. (PMID: 10348794)
Roy P, Tretyakov O, Wright J, Waxman DJ: Stereoselective metabolism of ifosfamide by human P-450s 3A4 and 2B6. Favorable metabolic properties of R-enantiomer. Drug Metab Dispos. 1999 Nov;27(11):1309-18. (PMID: 10534317)

>  <Comments>  (35) 
5 (N for N-Dechloroethylation). 2 (N for N-Dechloroethylation).

$$$$
CC02116
     RDKit          3D

  8  8  0  0  0  0  0  0  0  0999 V2000
    1.1900    0.6800    0.1770 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.3970    1.2320    0.8440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4400    2.2210    1.7380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1060    1.3910    0.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3270    0.6470    0.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3030   -0.6240   -0.2870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0630   -1.4470   -0.3250 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1090   -0.8150    0.4040 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  1
  1  4  1  0
  1  8  1  0
  2  3  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
M  END
>  <Name>  (36) 
4-Vinylcyclohexene

>  <InChIKey>  (36) 
BBDKZWKEPDTENS-MRVPVSSYSA-N

>  <PubChem_CID>  (36) 
638078

>  <CYP1A2>  (36) 


>  <CYP2A6>  (36) 


>  <CYP2B6>  (36) 
<0,1;Epoxidation;R1>
<4,5;Epoxidation;R2>

>  <CYP2C8>  (36) 


>  <CYP2C9>  (36) 


>  <CYP2C19>  (36) 


>  <CYP2D6>  (36) 


>  <CYP2E1>  (36) 
<0,1;Epoxidation;R1>
<4,5;Epoxidation;R2>

>  <CYP3A4>  (36) 


>  <References>  (36) 
Fontaine SM, Mash EA, Hoyer PB, Sipes IG: Stereochemical aspects of vinylcyclohexene bioactivation in rodent hepatic microsomes and purified human cytochrome P450 enzyme systems. Drug Metab Dispos. 2001 Feb;29(2):179-84. (PMID: 11159809)

>  <Comments>  (36) 


$$$$
CC02125
     RDKit          3D

 16 16  0  0  0  0  0  0  0  0999 V2000
   -2.7640    0.4950   -0.0760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6190   -0.5240   -0.4610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1440   -1.8160   -0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8150   -2.0980   -0.3740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9450   -1.0750    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4300    0.2280    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4750   -1.3680    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4100   -0.2620    0.6860 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.4240   -0.1570    2.2120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7650   -0.5580    0.2030 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2570    0.6630   -0.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7000    0.4500   -0.9090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3780    0.9830   -1.6610 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2040    1.8280    0.5410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3680    2.1130    0.1000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8930   -2.4990    0.1390 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 15  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  7 16  2  0
  8  9  1  1
  8 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 11 14  1  0
M  END
>  <Name>  (37) 
Bupropion

>  <InChIKey>  (37) 
SNPPWIUOZRMYNY-SECBINFHSA-N

>  <PubChem_CID>  (37) 
688387

>  <CYP1A2>  (37) 


>  <CYP2A6>  (37) 


>  <CYP2B6>  (37) 
<4,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>
<11,H;Hydroxylation;R4>
<12,H;Hydroxylation;R5>

>  <CYP2C8>  (37) 


>  <CYP2C9>  (37) 


>  <CYP2C19>  (37) 
<0,H;Hydroxylation;R1>
<11,H;Hydroxylation;R2>
<12,H;Hydroxylation;R3>

>  <CYP2D6>  (37) 


>  <CYP2E1>  (37) 
<11,H;Hydroxylation;R1>
<12,H;Hydroxylation;R2>

>  <CYP3A4>  (37) 
<4,H;Hydroxylation;R1>
<5,H;Hydroxylation;R2>
<6,H;Hydroxylation;R3>

>  <References>  (37) 
Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, Lindley CM: Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos. 2000 Oct;28(10):1222-30. (PMID: 10997944)
Faucette SR, Hawke RL, Shord SS, Lecluyse EL, Lindley CM: Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation. Drug Metab Dispos. 2001 Aug;29(8):1123-9. (PMID: 11454731)

>  <Comments>  (37) 


$$$$
CC02134
     RDKit          3D

  6  5  0  0  0  0  0  0  0  0999 V2000
   -0.3740   -0.3580   -0.2810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0490    0.0580    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4990   -0.3390    1.3960 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2040   -1.7720    1.7840 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6410   -2.8150    0.7790 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0590   -2.6050    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
M  END
>  <Name>  (38) 
Hexane

>  <InChIKey>  (38) 
VLKZOEOYAKHREP-UHFFFAOYSA-N

>  <PubChem_CID>  (38) 
8058

>  <CYP1A2>  (38) 


>  <CYP2A6>  (38) 


>  <CYP2B6>  (38) 
<1,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>
<3,H;Hydroxylation;R3>
<4,H;Hydroxylation;R4>
<5,H;Hydroxylation;R5>
<0,H;Hydroxylation;R6>

>  <CYP2C8>  (38) 


>  <CYP2C9>  (38) 


>  <CYP2C19>  (38) 


>  <CYP2D6>  (38) 


>  <CYP2E1>  (38) 
<1,H;Hydroxylation;R1>
<4,H;Hydroxylation;R2>

>  <CYP3A4>  (38) 


>  <References>  (38) 
Crosbie SJ, Blain PG, Williams FM: Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers. Hum Exp Toxicol. 1997 Mar;16(3):131-7. doi: 10.1177/096032719701600301. (PMID: 9088965)
Iba MM, Fung J, Gonzalez FJ: Functional Cyp2e1 is required for substantial in vivo formation of 2,5-hexanedione from n-hexane in the mouse. Arch Toxicol. 2000 Dec;74(10):582-6. (PMID: 11201664)

>  <Comments>  (38) 
Reaction type of CYP2E1 needs to be confirmed.

$$$$
CC02143
     RDKit          3D

 23 26  0  0  1  0  0  0  0  0999 V2000
    0.7560   -3.0120    0.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6910   -2.0010    0.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3430   -0.6950   -0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0330   -0.3960   -0.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9040   -1.4390   -0.5500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5410   -2.7290   -0.2390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7120   -4.0070   -0.3430 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.4290    0.9650   -0.7720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3420    0.2820   -0.0740 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3780    0.3740    0.7980 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1170    1.3950    0.4520 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6330   -0.5430    1.9660 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5770    1.9920   -0.6240 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4640    1.3190   -0.9550 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4910    1.6430   -2.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1800    1.8780   -1.4440 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7580    1.3320   -0.2320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8160    1.6010   -1.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9590    1.4040    1.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0520    1.9430   -0.5910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030    1.7480    1.6450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2450    2.0190    0.7770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9410    1.1390    1.9970 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  3  9  1  0
  4  5  1  0
  4  8  1  0
  5  6  2  0
  6  7  1  0
  8 16  2  0
  8 17  1  0
  9 10  1  0
  9 14  1  0
 10 11  2  0
 10 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 17 18  2  0
 17 19  1  0
 18 20  1  0
 19 21  2  0
 19 23  1  0
 20 22  2  0
 21 22  1  0
M  END
>  <Name>  (39) 
Midazolam

>  <InChIKey>  (39) 
DDLIGBOFAVUZHB-UHFFFAOYSA-N

>  <PubChem_CID>  (39) 
4192

>  <CYP1A2>  (39) 


>  <CYP2A6>  (39) 


>  <CYP2B6>  (39) 
<0,H;Hydroxylation;R1>

>  <CYP2C8>  (39) 


>  <CYP2C9>  (39) 


>  <CYP2C19>  (39) 


>  <CYP2D6>  (39) 


>  <CYP2E1>  (39) 


>  <CYP3A4>  (39) 
<0,H;Hydroxylation;R1>
<22,H;Hydroxylation;R2>

>  <References>  (39) 
Ekins S, Vandenbranden M, Ring BJ, Gillespie JS, Yang TJ, Gelboin HV, Wrighton SA: Further characterization of the expression in liver and catalytic activity of CYP2B6. J Pharmacol Exp Ther. 1998 Sep;286(3):1253-9. (PMID: 9732386)
Khan KK, He YQ, Domanski TL, Halpert JR: Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation. Mol Pharmacol. 2002 Mar;61(3):495-506. doi: 10.1124/mol.61.3.495. (PMID: 11854429)

>  <Comments>  (39) 


$$$$
CC02152
     RDKit          3D

 19 21  0  0  0  0  0  0  0  0999 V2000
   -3.3840    3.5470   -0.9610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6730    4.1890   -2.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6380    4.6850   -3.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3770    5.6330   -3.9220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8170    3.9850   -3.3150 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2860    2.9320   -2.5600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3080    2.3310   -2.8870 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4440    2.5220   -1.3570 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.9530    1.1600   -1.5430 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1300    0.7390   -2.5560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6770    1.3650   -3.4950 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8950   -0.6870   -2.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1420   -1.5910   -3.0610 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1140   -2.9120   -2.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8290   -3.2910   -1.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5850   -2.3560   -0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5970   -1.0600   -1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2750    0.1270   -0.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9640    0.1360    0.3080 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  8  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  6
  9 10  1  0
  9 18  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 17  2  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
M  END
>  <Name>  (40) 
Thalidomide

>  <InChIKey>  (40) 
UEJJHQNACJXSKW-VIFPVBQESA-N

>  <PubChem_CID>  (40) 
92142

>  <CYP1A2>  (40) 
<11,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>

>  <CYP2A6>  (40) 


>  <CYP2B6>  (40) 
<2,H;Hydroxylation;R1>

>  <CYP2C8>  (40) 


>  <CYP2C9>  (40) 
<11,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>
<9,H;Hydroxylation;R3>
<10,H;Hydroxylation;R3>
<11,H;Hydroxylation;R4>
<12,H;Hydroxylation;R4>

>  <CYP2C19>  (40) 
<11,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>
<9,H;Hydroxylation;R3>
<10,H;Hydroxylation;R3>
<11,H;Hydroxylation;R4>
<12,H;Hydroxylation;R4>
<2,H;Hydroxylation;R5>

>  <CYP2D6>  (40) 


>  <CYP2E1>  (40) 
<11,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>

>  <CYP3A4>  (40) 


>  <References>  (40) 
Ando Y, Fuse E, Figg WD: Thalidomide metabolism by the CYP2C subfamily. Clin Cancer Res. 2002 Jun;8(6):1964-73. (PMID: 12060642)

>  <Comments>  (40) 
Need to confirm. The metabolites are not confirmed and Xenosite used wrong SoMs.

$$$$
CC02161
     RDKit          3D

 19 19  0  0  0  0  0  0  0  0999 V2000
    0.0140    1.4260   -0.0640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0060    0.1010   -0.4940 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1320    1.9150    0.6090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1010    2.1650   -0.3480 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0870   -0.7290   -0.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2240    1.0820    0.8480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9850    3.4980    0.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2100   -0.2460    0.4180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1450    4.3390   -0.3510 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.3490   -1.1840    0.6470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9570    5.7610    0.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1290    6.5780   -0.1420 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8850    7.9360    0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1580    8.7250    0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7810    8.5870   -0.4910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1770    4.3070   -1.7720 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5640   -0.5490    1.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5590   -1.5470    1.4410 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6820   -0.9200    2.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  3  6  2  0
  4  7  1  0
  5  8  2  0
  6  8  1  0
  7  9  1  0
  8 10  1  0
  9 11  1  0
  9 16  1  6
 10 17  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 17 18  1  0
 18 19  1  0
M  END
>  <Name>  (41) 
Metoprolol

>  <InChIKey>  (41) 
IUBSYMUCCVWXPE-CQSZACIVSA-N

>  <PubChem_CID>  (41) 
157717

>  <CYP1A2>  (41) 


>  <CYP2A6>  (41) 


>  <CYP2B6>  (41) 


>  <CYP2C8>  (41) 


>  <CYP2C9>  (41) 


>  <CYP2C19>  (41) 
<13,14;Cleavage;R1>
<14,H;Oxidation;R1>

>  <CYP2D6>  (41) 
<3,H;Hydroxylation;R1>
<0,1;Cleavage;R2>
<0,H;Oxidation;R2>

>  <CYP2E1>  (41) 


>  <CYP3A4>  (41) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <References>  (41) 
Bapiro TE, Hasler JA, Ridderstrom M, Masimirembwa CM: The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations. Biochem Pharmacol. 2002 Nov 1;64(9):1387-98. doi: 10.1016/s0006-2952(02)01351-5. (PMID: 12392820)
Rendic S: Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448. doi: 10.1081/DMR-120001392. (PMID: 11996015)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)

>  <Comments>  (41) 
Rendic-2002 cannot be found in PubMed. It's replaced.

$$$$
CC02170
     RDKit          3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -4.1810   -0.7350    0.4410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3930   -0.3700    1.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0190   -0.1760    1.3990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6070   -0.9130   -0.8180 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2450   -0.7190   -0.9400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4610   -0.3540    0.1430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5840   -0.9230    0.6120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7260   -1.0760    0.7510 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4020   -0.8360   -2.1540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0480   -0.6450   -1.6820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0400   -0.2080   -0.2950 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.8330   -1.1620    0.5160 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4510    1.2250   -0.2210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1100    2.1490   -1.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080    1.6740    0.8690 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5190    3.4780   -1.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6220    3.0010    0.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2730    3.8920   -0.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0030   -1.7410   -0.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7710   -2.6840    0.6530 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8940   -3.2800   -0.0470 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8800   -2.2480   -0.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5140   -4.2220    0.8680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6630    5.1710    0.0340 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  4  1  0
  1  7  1  0
  2  3  1  0
  3  6  2  0
  4  5  2  0
  5  6  1  0
  5  9  1  0
  6 11  1  0
  7  8  3  0
  9 10  1  0
 10 11  1  0
 11 12  1  1
 11 13  1  0
 12 19  1  0
 13 14  2  0
 13 15  1  0
 14 16  1  0
 15 17  2  0
 16 18  2  0
 17 18  1  0
 18 24  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
M  END
>  <Name>  (42) 
Citalopram

>  <InChIKey>  (42) 
WSEQXVZVJXJVFP-FQEVSTJZSA-N

>  <PubChem_CID>  (42) 
146570

>  <CYP1A2>  (42) 


>  <CYP2A6>  (42) 


>  <CYP2B6>  (42) 


>  <CYP2C8>  (42) 


>  <CYP2C9>  (42) 


>  <CYP2C19>  (42) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidaiton;R2>

>  <CYP2D6>  (42) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidaiton;R2>
<1,N;N-Oxidation;R3>

>  <CYP2E1>  (42) 


>  <CYP3A4>  (42) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>
<1,2;Cleavage;R2>
<2,H;Oxidaiton;R2>

>  <References>  (42) 
Olesen OV, Linnet K: Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes. Pharmacology. 1999 Dec;59(6):298-309. doi: 10.1159/000028333. (PMID: 10575324)

>  <Comments>  (42) 


$$$$
CC02179
     RDKit          3D

 26 28  0  0  0  0  0  0  0  0999 V2000
   -1.1890    1.9350   -0.8000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6610    1.5300   -0.9100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0760    0.7900    0.3650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1310   -0.3970    0.5810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6880    0.1090    0.6130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3540    0.7360   -0.6700 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0360    1.1990   -0.5640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9930    1.6770    1.4820 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4900    0.2890    0.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2960    0.1630    1.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5930   -0.2960    1.2040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0840   -0.6290   -0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2770   -0.5030   -1.1620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9820   -0.0380   -1.0290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7130   -1.2060   -0.2130 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.9660   -0.0070   -0.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4140    0.4750   -0.3150 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3300   -0.7130   -0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7810   -0.5120   -0.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6350   -1.6140    0.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9940   -1.4190    0.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5160   -0.1340    0.1780 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6750    0.9630    0.0530 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3150    0.7810   -0.0690 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8500    0.0510    0.2910 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8710   -1.8360   -0.1700 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  3  8  1  0
  3  9  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7 16  1  0
  9 10  2  0
  9 14  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 15  1  0
 13 14  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 26  2  0
 19 20  2  0
 19 24  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 25  1  0
 23 24  2  0
M  END
>  <Name>  (43) 
Haloperidol

>  <InChIKey>  (43) 
LNEPOXFFQSENCJ-UHFFFAOYSA-N

>  <PubChem_CID>  (43) 
3559

>  <CYP1A2>  (43) 


>  <CYP2A6>  (43) 


>  <CYP2B6>  (43) 


>  <CYP2C8>  (43) 
<4,5;Cleavage;R1>
<4,H;Oxidation;R1>

>  <CYP2C9>  (43) 
<4,5;Cleavage;R1>
<4,H;Oxidation;R1>

>  <CYP2C19>  (43) 
<4,5;Cleavage;R1>
<4,H;Oxidation;R1>

>  <CYP2D6>  (43) 
<4,5;Cleavage;R1>
<4,H;Oxidation;R1>

>  <CYP2E1>  (43) 


>  <CYP3A4>  (43) 
<8,9;Reduction;R1>
<4,5;Cleavage;R2>
<4,H;Oxidation;R2>
<0,1;Reduction;R3>

>  <References>  (43) 
Avent KM, DeVoss JJ, Gillam EM: Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites. Chem Res Toxicol. 2006 Jul;19(7):914-20. doi: 10.1021/tx0600090. (PMID: 16841959)
Fang J, McKay G, Song J, Remillrd A, Li X, Midha K: In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Drug Metab Dispos. 2001 Dec;29(12):1638-43. (PMID: 11717183)

>  <Comments>  (43) 
Need to confirm. Xenosite reports 1,5 as SoM, but not reported in other papers.

$$$$
CC02188
     RDKit          3D

 40 43  0  0  1  0  0  0  0  0999 V2000
    5.2900    0.4210    2.9310 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.3260   -3.1890   -1.2740 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4600    2.1450    0.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6760    2.5380   -0.4600 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2890    3.4580   -5.7610 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3320   -1.3780    0.3810 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3860   -1.6180   -2.6070 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8440    1.8610   -0.8220 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0890   -3.7540    0.7360 C   0  0  2  0  0  0  0  0  0  0  0  0
    9.1700   -2.5370    1.6230 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.8470   -3.7800   -0.1180 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8720   -1.7640    1.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3440   -5.0730    1.4130 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6910   -2.8070    3.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5390   -2.3960   -0.6590 C   0  0  1  0  0  0  0  0  0  0  0  0
   10.5890   -5.0630    2.2710 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8460   -3.7790    3.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9940   -0.1570   -0.0600 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2930   -2.4750   -1.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5980    1.0860    0.7210 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.1470    1.5130    0.5510 C   0  0  2  0  0  0  0  0  0  0  0  0
    5.3560   -1.4580   -3.6100 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1400    0.5370    1.1250 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8250   -0.4550   -4.6370 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0790   -2.7670   -4.3170 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0720   -0.9530   -2.9920 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6260    2.3630   -1.2170 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4950    2.6770   -2.6630 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4980   -1.1510    3.1990 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5640    2.9340   -3.5360 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1810    2.7150   -3.1500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9840   -1.9240    2.1580 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4060   -1.6280    4.5070 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2770    3.2070   -4.8780 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9900    2.9560   -3.0910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9200    2.9910   -4.4890 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3850   -3.1540    2.4170 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8070   -2.8580    4.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9730    3.2360   -5.3600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2970   -3.6210    3.7250 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 23  1  0
  1 29  1  0
  2 19  2  0
 20  3  1  6
  4 27  2  0
  5 34  1  0
  6 12  1  0
  6 15  1  0
  6 18  1  0
  7 19  1  0
  7 22  1  0
  8 21  1  0
  8 27  1  0
  9 10  1  0
  9 11  1  1
  9 13  1  0
 10 12  1  1
 10 14  1  0
 11 15  1  0
 13 16  1  0
 14 17  1  0
 15 19  1  1
 16 17  1  0
 18 20  1  0
 20 21  1  0
 21 23  1  6
 22 24  1  0
 22 25  1  0
 22 26  1  0
 27 28  1  0
 28 30  2  0
 28 31  1  0
 29 32  2  0
 29 33  1  0
 30 34  1  0
 30 35  1  0
 31 36  2  0
 32 37  1  0
 33 38  2  0
 34 39  2  0
 36 39  1  0
 37 40  2  0
 38 40  1  0
M  END
>  <Name>  (44) 
Nelfinavir

>  <InChIKey>  (44) 
QAGYKUNXZHXKMR-HKWSIXNMSA-N

>  <PubChem_CID>  (44) 
64143

>  <CYP1A2>  (44) 


>  <CYP2A6>  (44) 


>  <CYP2B6>  (44) 


>  <CYP2C8>  (44) 


>  <CYP2C9>  (44) 


>  <CYP2C19>  (44) 
<37,H;Hydroxylation;R1>
<38,H;Hydroxylation;R2>
<39,H;Hydroxylation;R3>

>  <CYP2D6>  (44) 


>  <CYP2E1>  (44) 


>  <CYP3A4>  (44) 
<3,H;UnspReduction;R1>
<4,H;Hydroxylation;R2>

>  <References>  (44) 
Hirani VN, Raucy JL, Lasker JM: Conversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19. Drug Metab Dispos. 2004 Dec;32(12):1462-7. doi: 10.1124/dmd.104.001743. Epub 2004 Sep 24. (PMID: 15448116)

>  <Comments>  (44) 
<5,34;UnspReduction> need to be confirmed.

$$$$
CC02197
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    1.4140    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200    0.0170    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2500    2.1520    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1910   -0.6680    0.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2290    3.6130   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1700    2.1090    0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1700    4.7200   -0.1200 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3500    0.0290    0.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2990    1.5470   -0.1270 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2930    4.4970   -0.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5020   -0.6480    1.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6860    6.2200   -0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3360    1.4180    0.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9890    5.8320   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4270   -0.8520   -0.2140 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2190   -2.4010    0.3480 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.4560    0.2830    1.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7440   -0.4210    1.7300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8190    0.6310    2.0350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0810    1.3880    0.8500 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  6  1  0
  2  4  1  0
  2 15  1  0
  3  5  1  0
  3  9  2  0
  4  8  2  0
  4 16  1  0
  5  7  1  0
  5 10  2  0
  6 13  2  0
  7 12  1  0
  8 11  1  0
  8 13  1  0
 10 14  1  0
 11 17  1  0
 12 14  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
M  END
>  <Name>  (45) 
Tienilic acid derivative

>  <InChIKey>  (45) 
UGJUNCJBZLALDV-UHFFFAOYSA-N

>  <PubChem_CID>  (45) 
3282572

>  <CYP1A2>  (45) 


>  <CYP2A6>  (45) 


>  <CYP2B6>  (45) 


>  <CYP2C8>  (45) 
<5,H;Hydroxylation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2C9>  (45) 
<5,H;Hydroxylation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>

>  <CYP2C19>  (45) 
<5,H;Hydroxylation;R1>
<11,12;Cleavage;R2>
<12,H;Oxidation;R2>
<13,H;Hydroxylation;R3>

>  <CYP2D6>  (45) 


>  <CYP2E1>  (45) 


>  <CYP3A4>  (45) 


>  <References>  (45) 
Minoletti C, Dijols S, Dansette PM, Mansuy D: Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18. Biochemistry. 1999 Jun 15;38(24):7828-36. doi: 10.1021/bi9903289. (PMID: 10387023)

>  <Comments>  (45) 
<18,H;Hydroxylation> is reported in Xenosite and the paper only says aliphatic hydroxylation.

$$$$
CC02206
     RDKit          3D

 30 32  0  0  0  0  0  0  0  0999 V2000
   -0.7390    1.3140   -0.9920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7300   -0.0090   -1.0050 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2980   -0.6720   -2.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1500    0.0370   -3.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1270    1.4230   -3.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3190    2.0210   -2.0280 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7780   -0.8650   -4.7080 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -1.1940    1.9600    0.1080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0960    3.3160    0.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0140    3.9180    0.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1170    5.2950    0.7410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8900    6.0760    0.1910 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0000    5.4730   -0.3860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1020    4.0970   -0.4110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3060    3.4420   -1.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7860    7.4740    0.2180 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4190    8.0620    0.0820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4230    7.3820    0.0080 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5100    9.4060    0.0290 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7140    9.9950   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7190    9.3140   -0.1810 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8140   11.4640   -0.1650 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6620   12.2510   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7620   13.6240   -0.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0010   14.2310   -0.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1480   13.4690   -0.3490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0670   12.0830   -0.3000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2200   11.3130   -0.3850 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9230   11.5570   -1.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1020   11.5580    0.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  8  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  8  9  1  0
  9 10  2  0
  9 14  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 16  1  0
 13 14  2  0
 14 15  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 22 27  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
M  END
>  <Name>  (46) 
BPU

>  <InChIKey>  (46) 
JNGQUJZDVFZPEN-UHFFFAOYSA-N

>  <PubChem_CID>  (46) 
368697

>  <CYP1A2>  (46) 


>  <CYP2A6>  (46) 


>  <CYP2B6>  (46) 


>  <CYP2C8>  (46) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>
<16,18;Cleavage;R2>
<18,H;Oxidation;R2>

>  <CYP2C9>  (46) 


>  <CYP2C19>  (46) 


>  <CYP2D6>  (46) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>
<16,18;Cleavage;R2>
<18,H;Oxidation;R2>

>  <CYP2E1>  (46) 


>  <CYP3A4>  (46) 
<16,17;Cleavage;R1>
<17,H;Oxidation;R1>
<16,18;Cleavage;R2>
<18,H;Oxidation;R2>

>  <References>  (46) 
Rudek MA, Zhao M, Smith NF, Robey RW, He P, Hallur G, Khan S, Hidalgo M, Jimeno A, Colevas AD, Messersmith WA, Wolff AC, Baker SD: In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agent. Clin Cancer Res. 2005 Dec 1;11(23):8503-11. doi: 10.1158/1078-0432.CCR-05-1037. (PMID: 16322314)

>  <Comments>  (46) 


$$$$
CC02215
     RDKit          3D

 33 35  0  0  0  0  0  0  0  0999 V2000
    1.0750   -0.9140   -0.6640 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7360   -2.2610   -0.8560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6530   -3.2350   -0.5910 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9250   -2.9120   -0.1320 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2860   -1.6100    0.0650 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3690   -0.5900   -0.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7140    0.8210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9750    1.2060    0.4590 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2570    2.5430    0.6310 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2980    3.5100    0.3520 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0580    3.1580   -0.0980 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7400    1.8040   -0.2840 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4620    1.4150   -0.7480 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1460    0.1180   -0.9350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2280   -0.2420   -1.4380 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.1710   -0.4360   -0.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5670   -0.8010   -0.7590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4720   -0.9880    0.3830 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5800    0.3150    1.0540 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0480    1.3690    0.0480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0990    2.7380    0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5670    3.7920   -0.2740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7980   -1.2860   -0.1740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7690   -1.6080    0.9640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1500   -1.9200    0.3830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1210   -2.2420    1.5210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7210    0.8100   -2.2700 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9160   -4.0110    0.1510 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3280   -5.2510   -0.1210 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.0440   -3.8430   -0.6590 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.2960   -3.9610    1.4970 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.8770    4.3830   -0.4400 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.8240    3.0250    1.2020 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 14  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4 28  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  2  0
  9 33  1  0
 10 11  1  0
 11 12  2  0
 11 32  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 27  1  6
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
M  END
>  <Name>  (47) 
Halofantrine

>  <InChIKey>  (47) 
FOHHNHSLJDZUGQ-RUZDIDTESA-N

>  <PubChem_CID>  (47) 
36688213

>  <CYP1A2>  (47) 


>  <CYP2A6>  (47) 


>  <CYP2B6>  (47) 


>  <CYP2C8>  (47) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>
<4,5;Cleavage;R2>
<5,H;Oxidation;R2>

>  <CYP2C9>  (47) 


>  <CYP2C19>  (47) 


>  <CYP2D6>  (47) 


>  <CYP2E1>  (47) 


>  <CYP3A4>  (47) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>
<4,5;Cleavage;R2>
<5,H;Oxidation;R2>

>  <References>  (47) 
Baune B, Flinois JP, Furlan V, Gimenez F, Taburet AM, Becquemont L, Farinotti R: Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5. J Pharm Pharmacol. 1999 Apr;51(4):419-26. doi: 10.1211/0022357991772628. (PMID: 10385214)

>  <Comments>  (47) 


$$$$
CC02224
     RDKit          3D

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0000    1.4140    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0200    0.0170    0.1920 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2500    2.1520    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1910   -0.6680    0.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2290    3.6130   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1700    2.1090    0.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1700    4.7200   -0.1200 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3500    0.0290    0.7650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8150   -0.3590    1.5660 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2990    1.5470   -0.1270 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2930    4.4970   -0.2200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5020   -0.6480    1.0040 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6860    6.2200   -0.2750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3360    1.4180    0.8300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9890    5.8320   -0.3070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8840   -1.5650    1.5230 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4270   -0.8520   -0.2140 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.2190   -2.4010    0.3480 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -4.5040    0.3300    1.2890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.9060    0.3650    1.8590 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  1  6  1  0
  2  4  1  0
  2 17  1  0
  3  5  1  0
  3 10  2  0
  4  8  2  0
  4 18  1  0
  5  7  1  0
  5 11  2  0
  6 14  2  0
  7 13  1  0
  8 12  1  0
  8 14  1  0
  9 16  2  0
  9 19  1  0
  9 20  1  0
 11 15  1  0
 12 19  1  0
 13 15  2  0
M  END
>  <Name>  (48) 
Tienilic acid

>  <InChIKey>  (48) 
AGHANLSBXUWXTB-UHFFFAOYSA-N

>  <PubChem_CID>  (48) 
38409

>  <CYP1A2>  (48) 


>  <CYP2A6>  (48) 


>  <CYP2B6>  (48) 


>  <CYP2C8>  (48) 
<14,H;Hydroxylation;R2>

>  <CYP2C9>  (48) 
<15,S;S-Oxidation;R1>
<14,H;Hydroxylation;R2>

>  <CYP2C19>  (48) 
<14,H;Hydroxylation;R2>

>  <CYP2D6>  (48) 


>  <CYP2E1>  (48) 


>  <CYP3A4>  (48) 


>  <References>  (48) 
Jean P, Lopez-Garcia P, Dansette P, Mansuy D, Goldstein JL: Oxidation of tienilic acid by human yeast-expressed cytochromes P-450 2C8, 2C9, 2C18 and 2C19. Evidence that this drug is a mechanism-based inhibitor specific for cytochrome P-450 2C9. Eur J Biochem. 1996 Nov 1;241(3):797-804. doi: 10.1111/j.1432-1033.1996.00797.x. (PMID: 8944768)
Lopez Garcia MP, Dansette PM, Valadon P, Amar C, Beaune PH, Guengerich FP, Mansuy D: Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10. Eur J Biochem. 1993 Apr 1;213(1):223-32. doi: 10.1111/j.1432-1033.1993.tb17752.x. (PMID: 8477697)
Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. (PMID: 19515014)

>  <Comments>  (48) 


$$$$
CC02233
     RDKit          3D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.4790    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1790    2.1960    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2320    2.1620    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7540   -0.7190    0.9290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7730   -0.6880   -0.9360 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1530    3.5790    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3610    1.5410   -0.0120 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2460    3.5420    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7320   -2.0990    0.9170 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7880   -2.0680   -0.9390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0560    4.2490    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0400   -2.7720   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0790    5.7560    0.0340 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.8080    6.2540   -1.1870 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7960    6.2480    1.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9530    7.5730   -1.3910 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2630    5.4670   -1.9820 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  6 11  2  0
  7 12  2  0
  9 12  1  0
 10 13  2  0
 11 13  1  0
 12 14  1  0
 14 15  1  0
 14 16  1  1
 15 17  1  0
 15 18  2  0
M  END
>  <Name>  (49) 
Flurbiprofen

>  <InChIKey>  (49) 
SYTBZMRGLBWNTM-JTQLQIEISA-N

>  <PubChem_CID>  (49) 
72099

>  <CYP1A2>  (49) 


>  <CYP2A6>  (49) 


>  <CYP2B6>  (49) 


>  <CYP2C8>  (49) 


>  <CYP2C9>  (49) 
<12,H;Hydroxylation;R1>

>  <CYP2C19>  (49) 


>  <CYP2D6>  (49) 


>  <CYP2E1>  (49) 


>  <CYP3A4>  (49) 


>  <References>  (49) 
Yamazaki H, Inoue K, Chiba K, Ozawa N, Kawai T, Suzuki Y, Goldstein JA, Guengerich FP, Shimada T: Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes. Biochem Pharmacol. 1998 Jul 15;56(2):243-51. doi: 10.1016/s0006-2952(98)00133-6. (PMID: 9698079)

>  <Comments>  (49) 


$$$$
CC02242
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
   -0.0220    1.7580    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1670    2.4640    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    2.4310    0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0240   -0.5080    1.5800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2600   -0.4040   -0.5140 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2650   -0.3700   -0.5380 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1520    3.8450    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2520    3.8120    0.0280 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0640   -0.2490    2.4070 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0590    4.5240    0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2010   -0.6110    3.7740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1630    0.3810    2.0850 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0780    5.9210    0.0360 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4200   -0.1380    4.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9250    0.4490    3.0220 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0810   -0.2460    5.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  2  7  2  0
  3  8  1  0
  4  9  2  0
  5 10  1  0
  8 11  2  0
  9 11  1  0
 10 12  1  0
 10 13  2  0
 11 14  1  0
 12 15  2  0
 13 16  1  0
 15 16  1  0
 15 17  1  0
M  END
>  <Name>  (50) 
Sulfamethoxazole

>  <InChIKey>  (50) 
JLKIGFTWXXRPMT-UHFFFAOYSA-N

>  <PubChem_CID>  (50) 
5329

>  <CYP1A2>  (50) 


>  <CYP2A6>  (50) 


>  <CYP2B6>  (50) 


>  <CYP2C8>  (50) 


>  <CYP2C9>  (50) 
<12,H;Hydroxylation;R1>

>  <CYP2C19>  (50) 


>  <CYP2D6>  (50) 


>  <CYP2E1>  (50) 


>  <CYP3A4>  (50) 


>  <References>  (50) 
Cribb AE, Spielberg SP, Griffin GP: N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab Dispos. 1995 Mar;23(3):406-14. (PMID: 7628308)

>  <Comments>  (50) 


$$$$
CC02251
     RDKit          3D

 24 26  0  0  0  0  0  0  0  0999 V2000
   -0.9050    0.3990    1.0720 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.9890    1.9220    1.1330 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.3740   -0.0340    1.0810 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.2090   -0.1020    2.2690 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4850    2.1980    0.9530 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.1980    2.5710    0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9510    1.0020    0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0790    0.3690    2.3820 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7380   -1.5050    2.0480 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2160    1.8850    2.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2610    2.3130    0.1110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4850   -2.7250    1.7240 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3630   -1.8590    3.3070 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5280   -1.3440    0.8430 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1970    3.2560    0.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2500   -3.2070    2.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6450   -3.2100    0.4300 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9320    4.7170    0.2920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2070   -4.1850    2.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6050   -4.1880    0.1890 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3860   -4.6740    1.2380 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2630    5.3550   -1.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1830    6.0420   -1.4770 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3380    5.3110   -1.6050 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  1
  2  5  1  0
  2  6  1  6
  3  7  1  0
  3  8  1  1
  4  9  1  0
  5  7  1  0
  5 10  1  1
  6 11  1  0
  8 10  1  0
  9 12  1  0
  9 13  2  0
  9 14  2  0
 11 15  2  0
 12 16  2  0
 12 17  1  0
 15 18  1  0
 16 19  1  0
 17 20  2  0
 18 22  1  0
 19 21  2  0
 20 21  1  0
 22 23  1  0
 22 24  2  0
M  END
>  <Name>  (51) 
Bisnor

>  <InChIKey>  (51) 
IBHYMKYJWOYNMU-KHECKTLASA-N

>  <PubChem_CID>  (51) 
101619702

>  <CYP1A2>  (51) 


>  <CYP2A6>  (51) 


>  <CYP2B6>  (51) 


>  <CYP2C8>  (51) 


>  <CYP2C9>  (51) 
<9,H;Hydroxylation;R1>

>  <CYP2C19>  (51) 


>  <CYP2D6>  (51) 


>  <CYP2E1>  (51) 


>  <CYP3A4>  (51) 
<9,H;Hydroxylation;R1>
<10,H;Hydroxylation;R2>

>  <References>  (51) 
Yamaguchi Y, Kirita S, Baba T, Aoyama J, Touchi A, Tukey RH, Guengerich FP, Matsubara T: Identification of rat and human cytochrome P450 forms involved in the metabolism of the thromboxane A2 receptor antagonist (+)-S-145. Drug Metab Dispos. 1997 Jan;25(1):75-80. (PMID: 9010633)

>  <Comments>  (51) 
The reference provied by Xenosite is wrong.

$$$$
CC02260
     RDKit          3D

 12 13  0  0  0  0  0  0  0  0999 V2000
   -0.0160    1.3210    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1480   -0.6650   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3380    0.0460   -0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2830    1.4310   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1040    2.0300    0.0020 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2330    1.9800    0.0190 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9340    3.4170    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2350    4.2130   -0.0880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8840    3.9180   -1.3710 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1830    2.4810   -1.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8820    1.6850   -1.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
M  END
>  <Name>  (52) 
1-PP

>  <InChIKey>  (52) 
MRBFGEHILMYPTF-UHFFFAOYSA-N

>  <PubChem_CID>  (52) 
88747

>  <CYP1A2>  (52) 


>  <CYP2A6>  (52) 


>  <CYP2B6>  (52) 


>  <CYP2C8>  (52) 


>  <CYP2C9>  (52) 


>  <CYP2C19>  (52) 


>  <CYP2D6>  (52) 
<0,H;Hydroxylation;R1>

>  <CYP2E1>  (52) 


>  <CYP3A4>  (52) 


>  <References>  (52) 
Raghavan N, Zhang D, Zhu M, Zeng J, Christopher L: Cyp2D6 catalyzes 5-hydroxylation of 1-(2-pyrimidinyl)-piperazine, an active metabolite of several psychoactive drugs, in human liver microsomes. Drug Metab Dispos. 2005 Feb;33(2):203-8. doi: 10.1124/dmd.104.001198. Epub 2004 Oct 26. (PMID: 15507542)

>  <Comments>  (52) 


$$$$
CC02269
     RDKit          3D

 13 13  0  0  0  0  0  0  0  0999 V2000
   -0.0130    1.0860    0.0080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6820    1.5470    1.1840 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6690    2.9050    1.1360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2530    3.6410    2.1560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2340    5.0220    2.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6330    5.6700    1.0450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0510    4.9380    0.0260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0670    3.5570    0.0700 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6140    7.1760    0.9950 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6470    7.6920    1.6900 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.7310    9.2120    1.5320 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5930    7.3520    3.1180 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9830    7.3000    3.5930 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  8  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  9  1  0
  7  8  2  0
  9 10  1  0
 10 11  1  1
 10 12  1  0
 12 13  1  0
M  END
>  <Name>  (53) 
PMMA

>  <InChIKey>  (53) 
UGFMBZYKVQSQFX-SECBINFHSA-N

>  <PubChem_CID>  (53) 
40463419

>  <CYP1A2>  (53) 


>  <CYP2A6>  (53) 


>  <CYP2B6>  (53) 


>  <CYP2C8>  (53) 


>  <CYP2C9>  (53) 


>  <CYP2C19>  (53) 


>  <CYP2D6>  (53) 
<9,10;Cleavage;R1>
<10,H;Oxidation;R1>

>  <CYP2E1>  (53) 


>  <CYP3A4>  (53) 


>  <References>  (53) 
Staack RF, Theobald DS, Paul LD, Springer D, Kraemer T, Maurer HH: Identification of human cytochrome P450 2D6 as major enzyme involved in the O-demethylation of the designer drug p-methoxymethamphetamine. Drug Metab Dispos. 2004 Apr;32(4):379-81. doi: 10.1124/dmd.32.4.379. (PMID: 15039289)

>  <Comments>  (53) 


$$$$
CC02278
     RDKit          3D

 22 26  0  0  0  0  0  0  0  0999 V2000
   -0.1360    1.5100   -0.0640 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.1200    0.0000   -0.0720 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160    1.9520   -0.0050 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.0160    1.7840    1.1400 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7540    2.0010   -1.3750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2370   -0.4310    0.6300 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8620   -0.8120   -0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0450    1.3270   -1.1920 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.9370    1.5230    1.3200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9160    0.6290    1.1200 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2880    1.7370    2.4690 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0670    1.4020   -2.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4490   -1.8100    0.7400 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0830   -0.1910   -1.1860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6370   -2.1740   -0.4830 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4640    1.8310   -2.4400 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1500    2.1970    2.4430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3180    0.3910    2.9490 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4960   -2.6450    0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5360   -2.3120    1.3840 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4500    3.2970   -2.3380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4400   -3.7360    1.3080 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  6
  2  6  2  0
  2  7  1  0
  3  8  1  0
  3  9  1  1
  4 10  1  1
  4 11  1  0
  5 12  1  0
  6 10  1  0
  6 13  1  0
  7 14  1  0
  7 15  2  0
  8 14  1  6
  8 16  1  0
  9 17  1  0
 11 17  1  0
 11 18  1  6
 12 16  1  0
 13 19  2  0
 13 20  1  0
 15 19  1  0
 16 21  1  0
 20 22  1  0
M  END
>  <Name>  (54) 
Dihydrocodeine

>  <InChIKey>  (54) 
RBOXVHNMENFORY-DNJOTXNNSA-N

>  <PubChem_CID>  (54) 
5284543

>  <CYP1A2>  (54) 


>  <CYP2A6>  (54) 


>  <CYP2B6>  (54) 


>  <CYP2C8>  (54) 


>  <CYP2C9>  (54) 


>  <CYP2C19>  (54) 


>  <CYP2D6>  (54) 
<0,1;Cleavage;R1>
<0,H;Oxidation;R1>

>  <CYP2E1>  (54) 


>  <CYP3A4>  (54) 
<17,18;Cleavage;R1>
<18,H;Oxidation;R1>

>  <References>  (54) 
Kirkwood LC, Nation RL, Somogyi AA: Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine. Br J Clin Pharmacol. 1997 Dec;44(6):549-55. doi: 10.1046/j.1365-2125.1997.t01-1-00626.x. (PMID: 9431830)
Zhou SF: Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000. (PMID: 19902987)

>  <Comments>  (54) 
Xenosite's reference is not available. New reference is added.

$$$$
CC02287
     RDKit          3D

 23 27  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3900    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0040    0.0010   -0.1070 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1420    2.1600    0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3130    2.0730    0.0190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0510   -0.7580    0.4000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0560   -0.6290   -0.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3160    1.6430    0.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1080    3.4770   -0.3340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8160    2.1910    1.4600 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4160   -0.0150    1.2200 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.0250   -2.1430    0.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0720   -2.0040   -0.8860 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4460    2.4510    0.7260 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2360    4.2710   -0.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1760    2.9030    1.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9880    0.8030    2.0920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8300    2.9980    2.3160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0320   -2.7600   -0.3810 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4040    3.7580    0.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6400    2.9900    2.9580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4850    0.9740    3.5270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3730    3.0830    3.7420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6700    2.3800    3.8580 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  2  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  2  0
  6 12  1  0
  7 10  1  0
  7 13  1  0
  8 14  2  0
  9 15  1  0
  9 16  1  0
  9 17  1  0
 11 18  1  0
 12 18  2  0
 13 19  2  0
 14 19  1  0
 15 20  1  0
 16 21  1  0
 17 22  1  0
 20 23  1  0
 21 23  1  0
 22 23  1  0
M  END
>  <Name>  (55) 
Mequitazine

>  <InChIKey>  (55) 
FXKSIMKLXMWGEF-UHFFFAOYSA-N

>  <PubChem_CID>  (55) 
15662541

>  <CYP1A2>  (55) 


>  <CYP2A6>  (55) 


>  <CYP2B6>  (55) 


>  <CYP2C8>  (55) 


>  <CYP2C9>  (55) 


>  <CYP2C19>  (55) 


>  <CYP2D6>  (55) 
<6,S;S-Oxidation;R1>
<0,H;Hydroxylation;R2>
<9,H;Hydroxylation;R3>

>  <CYP2E1>  (55) 


>  <CYP3A4>  (55) 


>  <References>  (55) 
Nakamura K, Yokoi T, Kodama T, Inoue K, Nagashima K, Shimada N, Shimizu T, Kamataki T: Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes. J Pharmacol Exp Ther. 1998 Feb;284(2):437-42. (PMID: 9454781)

>  <Comments>  (55) 


$$$$
CC02296
     RDKit          3D

 30 34  0  0  1  0  0  0  0  0999 V2000
   -0.0180    1.4610    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1850    2.3700    0.0040 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2610    1.8330    0.0180 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3400   -0.4190    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0250   -0.9560   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1470    3.2610   -1.2420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1640    3.2570    1.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1000    0.6950    0.0160 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6360   -1.7760    0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7160   -2.2860   -0.0170 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3070    4.2570   -1.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3230    4.2530    1.1800 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6110   -2.7010   -0.0070 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1680    5.1120    0.0010 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8990   -4.0210   -0.0110 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.3130    6.0310   -0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1050    7.1120    1.0570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2800    8.0560    1.0510 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4460    7.7630    1.7820 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2450    9.2130    0.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4820    8.6400    1.7620 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5250    6.7310    2.4270 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3000   10.0240    0.3400 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0180    9.5720   -0.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3920    9.7580    1.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6500    8.3020    2.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5160   10.7590    0.9200 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8820    9.0800    2.1260 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5130   10.5670    2.0620 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  2  0
  2  5  2  0
  2  6  1  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5  9  1  0
  5 10  1  0
  6 11  2  0
  7 12  1  0
  8 13  1  0
 10 14  2  0
 11 14  1  0
 12 15  1  0
 13 15  1  0
 14 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 20 22  1  0
 20 23  2  0
 21 24  1  0
 21 25  1  0
 22 26  1  0
 22 27  1  0
 24 26  2  0
 26 28  1  0
 27 29  1  0
 28 30  1  0
 29 30  1  0
M  END
>  <Name>  (56) 
Risperidone

>  <InChIKey>  (56) 
RAPZEAPATHNIPO-UHFFFAOYSA-N

>  <PubChem_CID>  (56) 
5073

>  <CYP1A2>  (56) 


>  <CYP2A6>  (56) 


>  <CYP2B6>  (56) 


>  <CYP2C8>  (56) 


>  <CYP2C9>  (56) 


>  <CYP2C19>  (56) 


>  <CYP2D6>  (56) 
<29,H;Hydroxylation;R1>
<27,H;Hydroxylation;R2>
<15,N;N-Oxidation;R3>

>  <CYP2E1>  (56) 


>  <CYP3A4>  (56) 
<29,H;Hydroxylation;R1>
<9,10;Cleavage;R2>
<9,H;Oxidation;R2>

>  <References>  (56) 
Shen WW: The metabolism of atypical antipsychotic drugs: an update. Ann Clin Psychiatry. 1999 Sep;11(3):145-58. (PMID: 10482125)

>  <Comments>  (56) 
28 (Hydroxylation). 29 (Hydroxylation). 4 (N for N-Dealkylation).

$$$$
CC02305
     RDKit          3D

 26 30  0  0  0  0  0  0  0  0999 V2000
   -0.0180    1.5020    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.1180    2.2410    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1060    2.3300    0.0310 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3110   -0.4640    0.4810 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1020   -0.5570    0.9060 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7240    3.6310    0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4940    1.6260   -0.0140 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6950    3.6330    0.0310 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3600   -1.9170    0.2820 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3400    0.1390   -0.3710 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0730   -2.0850    0.8210 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.4510    4.8260    0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4020    4.8340    0.0460 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3270   -2.5810    1.1920 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.0920   -2.6940    1.7830 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.7280    5.9930    0.0240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6580    6.0000    0.0390 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3760   -4.1010    1.0400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0500   -4.2200    1.6530 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.7500   -2.2990    3.1960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6490   -4.7310    1.9880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9950   -4.8000    2.5540 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5140   -2.7240    4.2150 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7880   -1.6010    3.4120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1840   -2.3430    5.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  1  1
  3  7  1  0
  3  8  1  0
  4  9  1  0
  5 10  1  0
  5 11  1  0
 12  6  1  1
  7  9  2  0
  7 13  1  0
  8 11  1  0
  9 14  1  0
 15 10  1  6
 12 15  1  0
 12 16  1  0
 13 17  2  0
 14 18  2  0
 15 19  1  0
 16 20  1  0
 16 21  1  1
 17 18  1  0
 19 22  1  0
 20 22  1  0
 20 23  1  1
 21 24  1  0
 21 25  2  0
 24 26  1  0
M  END
>  <Name>  (57) 
Yohimbine

>  <InChIKey>  (57) 
BLGXFZZNTVWLAY-CCZXDCJGSA-N

>  <PubChem_CID>  (57) 
21603871

>  <CYP1A2>  (57) 


>  <CYP2A6>  (57) 


>  <CYP2B6>  (57) 


>  <CYP2C8>  (57) 


>  <CYP2C9>  (57) 


>  <CYP2C19>  (57) 


>  <CYP2D6>  (57) 
<12,H;Hydroxylation;R1>
<13,H;Hydroxylation;R2>

>  <CYP2E1>  (57) 


>  <CYP3A4>  (57) 
<12,H;Hydroxylation;R1>
<13,H;Hydroxylation;R2>

>  <References>  (57) 
Le Corre P, Parmer RJ, Kailasam MT, Kennedy BP, Skaar TP, Ho H, Leverge R, Smith DW, Ziegler MG, Insel PA, Schork NJ, Flockhart DA, O'connor DT: Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism. Clin Pharmacol Ther. 2004 Aug;76(2):139-53. doi: 10.1016/j.clpt.2004.04.010. (PMID: 15289791)

>  <Comments>  (57) 
17 (Aromatic Hydroylation). 18 (Aromatic Hydroylation).

$$$$
CC02314
     RDKit          3D

 23 27  0  0  1  0  0  0  0  0999 V2000
    2.3080   -0.3280    0.5930 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4260   -1.6450   -1.5880 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8000    2.4470    0.0450 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.2790   -1.4560    1.1530 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4680   -1.4050    0.5060 C   0  0  1  0  0  0  0  0  0  0  0  0
    5.4330   -2.2110   -0.3480 C   0  0  2  0  0  0  0  0  0  0  0  0
    6.8110   -1.5270   -0.2420 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.9630   -1.6090    0.3460 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.9290   -1.4230    1.9570 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4930    0.0160    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8180   -0.0940   -0.8110 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3220   -2.0250    2.0960 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5690    0.6770   -0.5140 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5540   -2.2410   -0.9900 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.9270   -2.5300   -1.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2450    0.5900    0.1810 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6180   -2.5410   -1.9880 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3880    2.0100   -0.8610 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4950   -2.2440    1.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0430    1.9180   -0.1380 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1390    2.6250   -0.6560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7550    3.8140   -0.3470 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3530    4.3220   -0.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
  8  1  1  6
  1 16  1  0
 14  2  1  6
  3 20  1  0
  3 22  1  0
  4  7  1  0
  4 12  1  0
  4 19  1  0
  5  6  1  0
  5  8  1  0
  5  9  1  1
  5 10  1  0
  6  7  1  0
  6 15  1  6
  7 11  1  1
  8 14  1  0
  9 12  1  0
 10 13  2  0
 10 16  1  0
 11 13  1  0
 13 18  1  0
 14 17  1  0
 15 17  2  0
 16 20  2  0
 18 21  2  0
 20 21  1  0
 22 23  1  0
M  END
>  <Name>  (58) 
Ethylmorphine

>  <InChIKey>  (58) 
OGDVEMNWJVYAJL-LEPYJNQMSA-N

>  <PubChem_CID>  (58) 
5359271

>  <CYP1A2>  (58) 


>  <CYP2A6>  (58) 


>  <CYP2B6>  (58) 


>  <CYP2C8>  (58) 


>  <CYP2C9>  (58) 


>  <CYP2C19>  (58) 


>  <CYP2D6>  (58) 
<18,19;Cleavage;R1>
<19,H;Oxidation;R1>

>  <CYP2E1>  (58) 


>  <CYP3A4>  (58) 
<1,2;Cleavage;R1>
<1,H;Oxidation;R1>

>  <References>  (58) 
Liu Z, Mortimer O, Smith CA, Wolf CR, Rane A: Evidence for a role of cytochrome P450 2D6 and 3A4 in ethylmorphine metabolism. Br J Clin Pharmacol. 1995 Jan;39(1):77-80. doi: 10.1111/j.1365-2125.1995.tb04413.x. (PMID: 7756104)

>  <Comments>  (58) 
4 (N for N-Demethylation). 3 (O for O-Deethylation).

$$$$
CC02323
     RDKit          2D

  6  6  0  0  0  0  0  0  0  0999 V2000
    1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300    0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2300   -0.7100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
M  END
>  <Name>  (59) 
Benzene

>  <InChIKey>  (59) 
UHOVQNZJYSORNB-UHFFFAOYSA-N

>  <PubChem_CID>  (59) 
241

>  <CYP1A2>  (59) 


>  <CYP2A6>  (59) 


>  <CYP2B6>  (59) 


>  <CYP2C8>  (59) 


>  <CYP2C9>  (59) 


>  <CYP2C19>  (59) 


>  <CYP2D6>  (59) 


>  <CYP2E1>  (59) 
<1,H;Hydroxylation;R1>
<2,H;Hydroxylation;R2>
<3,H;Hydroxylation;R3>
<4,H;Hydroxylation;R4>
<5,H;Hydroxylation;R5>
<0,H;Hydroxylation;R6>
<1,2;EpOxidation;R7>
<2,3;EpOxidation;R8>
<3,4;EpOxidation;R9>
<4,5;EpOxidation;R10>
<5,0;EpOxidation;R11>
<0,1;EpOxidation;R12>

>  <CYP3A4>  (59) 


>  <References>  (59) 
Snyder R, Chepiga T, Yang CS, Thomas H, Platt K, Oesch F: Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. Toxicol Appl Pharmacol. 1993 Oct;122(2):172-81. doi: 10.1006/taap.1993.1185. (PMID: 8211999)

>  <Comments>  (59) 
Benzene has both detectable phenol and dihydrodiol metabolites.

$$$$
CC02332
     RDKit          3D

 20 19  0  0  0  0  0  0  0  0999 V2000
   -2.6610    2.3610    0.7480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1450    1.6430   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6640    2.3660   -1.7590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1520    3.8120   -1.7500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6260    3.8120   -1.7550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1120    3.0880   -3.0060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6280    3.8030   -4.2490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1150    5.2580   -4.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2500    5.2550   -4.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9750    3.9900   -4.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2180    2.6870   -4.2530 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3450    2.5990   -5.5040 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2230    2.6860   -6.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2130    1.5160   -6.7520 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4580    0.1950   -6.7510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5680    0.1050   -7.9970 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4600    0.1970   -9.2440 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3370   -0.8390   -9.2590 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3330   -1.6340   -8.3450 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2150   -0.9710  -10.2490 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
M  END
>  <Name>  (60) 
Oleic acid

>  <InChIKey>  (60) 
ZQPPMHVWECSIRJ-KTKRTIGZSA-N

>  <PubChem_CID>  (60) 
445639

>  <CYP1A2>  (60) 


>  <CYP2A6>  (60) 


>  <CYP2B6>  (60) 


>  <CYP2C8>  (60) 


>  <CYP2C9>  (60) 


>  <CYP2C19>  (60) 


>  <CYP2D6>  (60) 


>  <CYP2E1>  (60) 
<0,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>

>  <CYP3A4>  (60) 


>  <References>  (60) 
Adas F, Salaun JP, Berthou F, Picart D, Simon B, Amet Y: Requirement for omega and (omega;-1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11. J Lipid Res. 1999 Nov;40(11):1990-7. (PMID: 10553002)

>  <Comments>  (60) 


$$$$
CC02341
     RDKit          3D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.3300    0.8800   -1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5700    1.4790   -1.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5060    1.3610   -0.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2020    0.6410    0.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9570    0.0410    0.7810 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0230    0.1670   -0.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3860    0.5600    0.1950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9160    0.6810    1.4660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8800    1.6380    1.7240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3130    2.4740    0.7120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7820    2.3530   -0.5590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8190    1.3960   -0.8170 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3310   -0.4790   -0.0850 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.3100   -1.4970    0.9800 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6030   -2.6720    0.3950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8140   -2.5500   -0.9210 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6790   -1.2700   -1.3310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8090   -0.8410   -2.4580 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6700   -3.7270    0.9950 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1210    0.5230    1.6440 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4 20  1  0
  5  6  2  0
 13  6  1  6
  7  8  2  0
  7 12  1  0
  7 13  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 13 14  1  0
 13 17  1  0
 14 15  1  0
 15 16  1  0
 15 19  2  0
 16 17  1  0
 17 18  2  0
M  END
>  <Name>  (61) 
3-HPPH

>  <InChIKey>  (61) 
FSPRLRPJSPWQNC-HNNXBMFYSA-N

>  <PubChem_CID>  (61) 
719589

>  <CYP1A2>  (61) 


>  <CYP2A6>  (61) 


>  <CYP2B6>  (61) 


>  <CYP2C8>  (61) 


>  <CYP2C9>  (61) 


>  <CYP2C19>  (61) 


>  <CYP2D6>  (61) 


>  <CYP2E1>  (61) 


>  <CYP3A4>  (61) 
<15,H;Hydroxylation;R1>

>  <References>  (61) 
Komatsu T, Yamazaki H, Asahi S, Gillam EM, Guengerich FP, Nakajima M, Yokoi T: Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Drug Metab Dispos. 2000 Nov;28(11):1361-8. (PMID: 11038165)

>  <Comments>  (61) 
3 (C for Aromatic Hydroxylation).

$$$$
CC02350
     RDKit          3D

 20 19  0  0  0  0  0  0  0  0999 V2000
   -0.0580   -0.0620   -0.1180 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2720   -0.6900    0.0180 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.2950    0.0780   -0.7890 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1250    0.2370   -2.0160 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1640   -2.1370   -0.5090 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7190   -3.0410   -0.4100 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.3140    0.5500   -0.2370 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9320   -0.1270    0.8860 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6100   -0.6780    1.9600 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3910   -4.6820   -1.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4500   -5.2660   -0.2810 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.8450   -4.5290   -2.3340 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.5850   -5.6590   -1.2030 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.5810   -5.1340   -2.2220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4780   -6.2040   -2.7750 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4740   -4.1080   -1.5900 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.9620   -6.9040   -1.5790 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6510   -8.0800   -1.1290 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9640   -9.1960   -1.5280 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3360    0.4130    0.7310 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  8  1  0
  2  3  1  0
  2  5  1  6
  3  4  2  0
  3  7  1  0
  5  6  1  0
  6 10  1  0
  8  9  2  0
  8 20  1  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
 13 14  1  0
 13 17  1  6
 14 15  1  0
 14 16  1  0
 17 18  1  0
 18 19  1  0
M  END
>  <Name>  (62) 
N-Ac-DFEC

>  <InChIKey>  (62) 
ZONTWFMTDBGILI-WDSKDSINSA-N

>  <PubChem_CID>  (62) 


>  <CYP1A2>  (62) 


>  <CYP2A6>  (62) 


>  <CYP2B6>  (62) 


>  <CYP2C8>  (62) 


>  <CYP2C9>  (62) 


>  <CYP2C19>  (62) 


>  <CYP2D6>  (62) 


>  <CYP2E1>  (62) 


>  <CYP3A4>  (62) 
<6,S;S-Oxidation;R1>

>  <References>  (62) 
Altuntas TG, Park SB, Kharasch ED: Sulfoxidation of cysteine and mercapturic acid conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A). Chem Res Toxicol. 2004 Mar;17(3):435-45. doi: 10.1021/tx034254k. (PMID: 15025515)

>  <Comments>  (62) 
6 (S for S-Oxidation).

$$$$
CC02359
     RDKit          3D

 18 19  0  0  1  0  0  0  0  0999 V2000
   -0.0170    1.3840    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2170   -0.6800   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4010    0.0320   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3780    1.4150   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1710    2.0900    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2480   -2.5700   -0.0230 Br  0  0  0  0  0  0  0  0  0  0  0  0
    4.0010    2.3860   -0.0230 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -1.3320    2.1200    0.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8700    2.1420    1.3860 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1440    2.8710    1.3270 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.0400    2.4260    2.4840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3680    3.1840    2.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1020    4.6870    2.5300 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.2060    5.1320    1.3730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8790    4.3740    1.4350 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4520    4.9680    3.7710 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1980   -0.7210    0.0100 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  9  1  0
  2  3  1  0
  2 18  1  0
  3  4  2  0
  3  7  1  0
  4  5  1  0
  5  6  2  0
  5  8  1  0
  9 10  1  0
 11 10  1  1
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 17  1  1
 15 16  1  0
M  END
>  <Name>  (63) 
Ambroxol

>  <InChIKey>  (63) 
JBDGDEWWOUBZPM-PHIMTYICSA-N

>  <PubChem_CID>  (63) 


>  <CYP1A2>  (63) 


>  <CYP2A6>  (63) 


>  <CYP2B6>  (63) 


>  <CYP2C8>  (63) 


>  <CYP2C9>  (63) 


>  <CYP2C19>  (63) 


>  <CYP2D6>  (63) 


>  <CYP2E1>  (63) 


>  <CYP3A4>  (63) 
<9,10;Cleavage;R1>
<9,H;Oxidation;R1>

>  <References>  (63) 
Ishiguro N, Senda C, Kishimoto W, Sakai K, Funae Y, Igarashi T: Identification of CYP3A4 as the predominant isoform responsible for the metabolism of ambroxol in human liver microsomes. Xenobiotica. 2000 Jan;30(1):71-80. (PMID: 10659952)

>  <Comments>  (63) 
Metabolic pathway to DHTQ cannot be identified. DHTQ is a minor product. Not record in BoM dataset.

$$$$
CC02368
     RDKit          3D

 27 28  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.4220    0.0100 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0800    0.0000   -0.0430 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3840    2.0370    0.0490 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.0960    0.1230   -1.3760 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1360    1.6480   -1.2280 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.7600    1.9280   -1.2290 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.0250    4.1020   -2.2950 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8850    3.3860   -1.1620 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6410   -0.3470   -1.3080 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.8520    6.2090   -3.5480 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1540    5.6020   -2.2260 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.5150    7.5380   -3.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0480    3.5400   -3.3690 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6160    6.0050   -1.9380 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1530    1.2980   -1.2800 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.5780   -2.1470   -1.5220 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8540    7.2780   -2.7760 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.8430   -0.4800   -0.3170 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2800    3.4600    0.1290 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5070    2.2560   -2.3590 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5950    6.4610   -3.5760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0740    1.7550    0.2010 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -3.2030    8.4560   -1.8650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2100   -2.3790   -1.7190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8960    1.8030   -2.5190 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5560    9.6750   -2.7200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9040   10.8540   -1.8090 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  6
  1  3  1  0
  1  6  1  0
  2  9  1  0
  3  5  1  0
  3 19  1  6
  4  5  1  0
  4  9  1  0
  4 18  1  1
  5 20  1  6
  6  8  1  1
  6 15  1  0
  7  8  1  0
 11  7  1  6
  7 13  2  0
  9 16  1  1
 10 11  1  0
 10 12  1  0
 10 21  1  0
 11 14  1  0
 12 17  1  0
 14 17  1  0
 15 22  1  0
 15 25  1  6
 16 24  1  0
 17 23  1  1
 23 26  1  0
 26 27  1  0
M  END
>  <Name>  (64) 
Clindamycin

>  <InChIKey>  (64) 
KDLRVYVGXIQJDK-AWPVFWJPSA-N

>  <PubChem_CID>  (64) 
446598

>  <CYP1A2>  (64) 


>  <CYP2A6>  (64) 


>  <CYP2B6>  (64) 


>  <CYP2C8>  (64) 


>  <CYP2C9>  (64) 


>  <CYP2C19>  (64) 


>  <CYP2D6>  (64) 


>  <CYP2E1>  (64) 


>  <CYP3A4>  (64) 
<13,S;S-Oxidation;R1>
<24,25;Cleavage;R2>
<25,H;Oxidation;R2>

>  <References>  (64) 
Wynalda MA, Hutzler JM, Koets MD, Podoll T, Wienkers LC: In vitro metabolism of clindamycin in human liver and intestinal microsomes. Drug Metab Dispos. 2003 Jul;31(7):878-87. doi: 10.1124/dmd.31.7.878. (PMID: 12814964)

>  <Comments>  (64) 
16 (S for S-Oxidation). 21 (N for N-Dealkylation).

$$$$
CC02377
     RDKit          3D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -0.8480   -0.3860   -1.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9750   -0.0250   -0.0010 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0370   -0.8570    0.7840 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.3000   -0.6140    0.5330 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.6450    1.4730    0.2280 C   0  0  2  0  0  0  0  0  0  0  0  0
    1.4300   -0.6230    0.1960 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.4900   -2.2830    0.5670 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5010   -0.4700   -0.4260 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.0100   -2.1260    0.7630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5070    2.3320   -0.5510 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7870    1.7690   -0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8160    0.8590    0.4220 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.4640   -1.6470    0.7360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4150   -1.6700   -0.1390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3080    0.8150   -0.1480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1460    0.9760   -0.3220 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.8500   -1.4000    0.0850 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7020   -1.6550   -0.9850 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8370    0.3130   -1.6860 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1920    0.0660    0.3760 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.6400    2.3530   -0.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4740   -2.8850   -0.5780 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6710    0.5140    0.2990 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0420    2.6360   -0.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.7230   -2.8940   -0.6380 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8580   -3.9110   -0.2250 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8600    1.4840   -0.8640 C   0  0  1  0  0  0  0  0  0  0  0  0
    7.2330    1.8390   -0.9820 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6
  2  3  1  0
  2  4  1  0
  2  5  1  0
  3  6  1  0
  3  7  1  6
  4  8  1  0
  4  9  1  6
  5 10  1  6
  5 11  1  0
  6 12  1  0
  6 13  1  1
  7  9  1  0
  8 14  1  0
  8 15  1  1
 12 11  1  6
 12 16  1  0
 13 17  1  0
 14 18  1  0
 16 19  1  6
 16 20  1  0
 16 21  1  0
 20 17  1  6
 18 22  1  0
 20 23  1  0
 21 24  1  0
 22 25  2  0
 22 26  1  0
 23 27  1  0
 24 27  1  0
 27 28  1  1
M  END
>  <Name>  (65) 
Deoxycholic acid

>  <InChIKey>  (65) 
KXGVEGMKQFWNSR-DNZDVJRKSA-N

>  <PubChem_CID>  (65) 
5283834

>  <CYP1A2>  (65) 


>  <CYP2A6>  (65) 


>  <CYP2B6>  (65) 


>  <CYP2C8>  (65) 


>  <CYP2C9>  (65) 


>  <CYP2C19>  (65) 


>  <CYP2D6>  (65) 


>  <CYP2E1>  (65) 


>  <CYP3A4>  (65) 
<19,H;Hydroxylation;R1>

>  <References>  (65) 
Barbier O, Trottier J, Kaeding J, Caron P, Verreault M: Lipid-activated transcription factors control bile acid glucuronidation. Mol Cell Biochem. 2009 Jun;326(1-2):3-8. doi: 10.1007/s11010-008-0001-5. Epub 2009 Jan 7. (PMID: 19130183)

>  <Comments>  (65) 


$$$$
CC02386
     RDKit          3D

 34 37  0  0  0  0  0  0  0  0999 V2000
    6.2090    3.7380   -0.8650 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4910    2.5770   -1.0810 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6900    4.0280    0.3980 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4490    3.1600    1.4460 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7260    2.0010    1.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2490    1.7090   -0.0330 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4670    0.4420   -0.2690 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4120   -0.6710   -0.6410 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9620   -1.4690    0.3450 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8300   -2.4890    0.0030 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1470   -2.7120   -1.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5970   -1.9140   -2.3090 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7240   -0.8970   -1.9680 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7610    0.0900    0.9230 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5750   -0.5940    0.5130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1690   -1.6060    1.5890 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8390   -2.2520    1.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2050   -1.2250    1.1120 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1460   -0.3350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4390    0.4160    0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4450   -1.9130    0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5810   -0.8950    0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8530   -1.6010    0.2240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0980   -0.8350    0.0550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8500   -2.8000    0.0460 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2800   -1.4860   -0.3120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4420   -0.7620   -0.4690 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.4420    0.6070   -0.2640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2760    1.2600    0.0990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1070    0.5480    0.2660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7170    1.3920   -0.4370 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.4480    2.8710   -0.1550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.2230    1.2310   -1.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.7730    0.8700    0.5390 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  3  1  0
  2  6  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7 14  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 14 15  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 21  1  0
 19 20  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 24 26  2  0
 24 30  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 28 31  1  0
 29 30  2  0
 31 32  1  0
 31 33  1  0
 31 34  1  0
M  END
>  <Name>  (66) 
Ebastine

>  <InChIKey>  (66) 
VPIRRYIYIPYTGX-UHFFFAOYSA-N

>  <PubChem_CID>  (66) 


>  <CYP1A2>  (66) 


>  <CYP2A6>  (66) 


>  <CYP2B6>  (66) 


>  <CYP2C8>  (66) 


>  <CYP2C9>  (66) 


>  <CYP2C19>  (66) 


>  <CYP2D6>  (66) 


>  <CYP2E1>  (66) 


>  <CYP3A4>  (66) 
<11,12;Cleavage;R1>
<11,H;Oxidation;R1>

>  <References>  (66) 
Hashizume T, Mise M, Terauchi Y, O L, Fujii T, Miyazaki H, Inaba T: N-Dealkylation and hydroxylation of ebastine by human liver cytochrome P450. Drug Metab Dispos. 1998 Jun;26(6):566-71. (PMID: 9616193)

>  <Comments>  (66) 


$$$$
CC02395
     RDKit          3D

 25 27  0  0  0  0  0  0  0  0999 V2000
    5.1580   -0.0720    0.3390 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7320   -0.5230    0.5200 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5760    1.1320    0.8730 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8840    1.5460    0.7060 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7750    0.7560    0.0050 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3580   -0.4490   -0.5300 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0510   -0.8660   -0.3570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8820   -0.0060   -0.6420 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4910   -0.4450   -0.4650 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7340    0.0820   -1.6060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7340   -0.3310   -1.4880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3230    0.2620   -0.2050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6970   -0.2150   -0.0290 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4670   -0.1810    0.9860 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9880    0.2240    0.7390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7580    0.6970   -0.0160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9390   -1.5320    0.1210 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1630    1.2760    1.1790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2110    2.1770    1.1880 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8560    2.5010    0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4540    1.9260   -1.1830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4040    1.0300   -1.2000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0320   -2.3310    0.0140 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3350   -2.0130    0.4220 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3130   -3.5230    0.6680 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  7  1  0
  2  8  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  8  9  1  0
  9 10  1  0
  9 15  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 13 16  1  0
 13 17  1  0
 14 15  1  0
 16 18  2  0
 16 22  1  0
 17 23  2  0
 17 24  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 24 25  1  0
M  END
>  <Name>  (67) 
Fentanyl

>  <InChIKey>  (67) 
PJMPHNIQZUBGLI-UHFFFAOYSA-N

>  <PubChem_CID>  (67) 
3345

>  <CYP1A2>  (67) 


>  <CYP2A6>  (67) 


>  <CYP2B6>  (67) 


>  <CYP2C8>  (67) 


>  <CYP2C9>  (67) 


>  <CYP2C19>  (67) 


>  <CYP2D6>  (67) 


>  <CYP2E1>  (67) 


>  <CYP3A4>  (67) 
<14,15;Cleavage;R1>
<15,H;Oxidation;R1>

>  <References>  (67) 
Labroo RB, Paine MF, Thummel KE, Kharasch ED: Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metab Dispos. 1997 Sep;25(9):1072-80. (PMID: 9311623)

>  <Comments>  (67) 


$$$$
CC02404
     RDKit          3D

 43 49  0  0  1  0  0  0  0  0999 V2000
   -0.5460    2.1440   -0.1460 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8330    2.4120   -0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4060    0.7930   -0.2880 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9850    1.0700   -0.4340 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5350    2.9470   -0.1440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7380    0.1430   -0.2560 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7100    1.1440   -0.0900 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8500    0.2460   -0.4330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0860   -1.1300   -0.3550 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3370    0.4280   -0.6140 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.9750    2.4570   -0.0090 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8180   -3.2510    0.9630 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0290    0.8210   -0.0270 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.1290   -3.5500    1.0530 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4160    1.4310   -0.2790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3870   -0.5380   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3640   -1.5080   -0.3020 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0020    3.3610   -0.2260 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2090    2.7020   -0.6980 O   0  0  0  0  0  0  0  0  0  0  0  0
  -12.2370   -6.3020    0.4300 N   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3360   -2.6650   -0.1500 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.4840   -5.0970    0.8040 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3900    4.1520   -0.0240 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7280   -0.9440   -0.0870 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4280   -5.4560    1.8510 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.8010   -4.5150   -0.4400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.6700   -4.1890    2.2610 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0460   -3.2400   -0.0520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0710   -3.5080    1.8860 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0370   -2.2710   -0.2020 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4110    1.1160    0.3300 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7200   -2.8660   -0.4100 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4480   -0.7000    0.2560 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0300   -3.2270   -0.3720 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4960   -0.0280   -2.0660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0800    1.8850    0.1600 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.2900   -5.8710   -0.4960 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.8970   -6.7810    1.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8680   -0.6800   -2.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5400    2.3940   -1.2070 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.1250   -7.0780   -0.9280 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.7120   -8.0380    1.3360 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.7920   -7.6950    0.3060 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  3  1  0
  1  5  1  0
  1 11  1  0
  2  4  2  0
  2  5  1  0
  2 18  1  0
  3  6  1  0
  3  8  2  0
  4  8  1  0
  4 10  1  0
  5 23  2  0
  6  7  2  0
  6  9  1  0
  7 11  1  0
  7 13  1  0
  9 17  2  0
 10 15  1  0
 10 33  1  1
 10 35  1  0
 12 14  1  0
 12 21  1  0
 12 29  2  0
 13 16  2  0
 13 36  1  0
 14 27  1  0
 14 28  1  0
 15 19  1  0
 15 31  2  0
 16 17  1  0
 16 24  1  0
 17 32  1  0
 18 19  1  0
 20 22  1  0
 20 37  1  0
 20 38  1  0
 21 30  1  0
 22 25  1  0
 22 26  1  0
 24 30  2  0
 25 27  1  0
 26 28  1  0
 30 34  1  0
 32 34  2  0
 35 39  1  0
 36 40  1  0
 37 41  1  0
 38 42  1  0
 41 43  1  0
 42 43  1  0
M  END
>  <Name>  (68) 
Irinotecan

>  <InChIKey>  (68) 
UWKQSNNFCGGAFS-XIFFEERXSA-N

>  <PubChem_CID>  (68) 
60838

>  <CYP1A2>  (68) 


>  <CYP2A6>  (68) 


>  <CYP2B6>  (68) 


>  <CYP2C8>  (68) 


>  <CYP2C9>  (68) 


>  <CYP2C19>  (68) 


>  <CYP2D6>  (68) 


>  <CYP2E1>  (68) 


>  <CYP3A4>  (68) 
<17,22;Cleavage;R1>
<22,H;Oxidation;R1>
<17,18;Cleavage;R2>
<18,H;Oxidation;R2>

>  <References>  (68) 
Sai K, Kaniwa N, Ozawa S, Sawada JI: A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3A4. Drug Metab Dispos. 2001 Nov;29(11):1505-13. (PMID: 11602529)

>  <Comments>  (68) 
41,42,43 might be SoMs as well.

$$$$
CC02413
     RDKit          3D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -3.5270    1.3220   -0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8420    0.8100    0.2750 C   0  0  2  0  0  0  0  0  0  0  0  0
   -4.8570   -0.6900    0.1310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3670    0.7280    0.4670 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.7380   -1.3870    0.1930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3900   -0.7810    0.4600 C   0  0  1  0  0  0  0  0  0  0  0  0
   -3.7830   -2.8540   -0.0120 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6640   -3.5160   -0.2470 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3080   -2.8820   -0.3090 C   0  0  1  0  0  0  0  0  0  0  0  0
   -1.3960   -1.3710   -0.5410 C   0  0  2  0  0  0  0  0  0  0  0  0
   -6.0290    1.4170   -0.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1150    1.1820   -0.1130 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5760   -3.1410    1.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0190   -0.7360   -0.3320 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0580   -1.6470   -0.9250 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4410   -1.0730   -0.6100 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.5210   -1.9860   -1.1970 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6190   -0.9950    0.8350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5460    2.3160    0.3240 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9030   -1.4590   -0.8010 C   0  0  2  0  0  0  0  0  0  0  0  0
    3.8520   -0.6990    1.3040 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0260   -1.4660    0.7270 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0120    0.1460    2.1520 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0620   -0.1240   -1.2880 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7530    2.7870   -0.2780 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.0760    2.9600    1.1980 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1810    4.0940    0.3920 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5660    3.0200   -1.7780 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5000    4.5720   -0.2180 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  2 11  1  6
  3  5  2  0
  4  6  1  0
  4 12  1  6
  6  5  1  6
  5  7  1  0
  6 10  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 13  1  1
 10 14  1  1
 12 19  1  0
 14 15  1  0
 16 15  1  1
 16 17  1  0
 16 18  1  0
 17 20  1  0
 18 21  1  0
 19 25  1  0
 19 26  2  0
 20 22  1  0
 20 24  1  1
 21 22  1  0
 21 23  2  0
 25 27  1  0
 25 28  1  6
 27 29  1  0
M  END
>  <Name>  (69) 
Lovastatin

>  <InChIKey>  (69) 
PCZOHLXUXFIOCF-BXMDZJJMSA-N

>  <PubChem_CID>  (69) 
53232

>  <CYP1A2>  (69) 


>  <CYP2A6>  (69) 


>  <CYP2B6>  (69) 


>  <CYP2C8>  (69) 


>  <CYP2C9>  (69) 


>  <CYP2C19>  (69) 


>  <CYP2D6>  (69) 


>  <CYP2E1>  (69) 


>  <CYP3A4>  (69) 
<1,H;Hydroxylation;R1>
<9,H;Hydroxylation;R2>

>  <References>  (69) 
Jacobsen W, Kirchner G, Hallensleben K, Mancinelli L, Deters M, Hackbarth I, Benet LZ, Sewing KF, Christians U: Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver. Drug Metab Dispos. 1999 Feb;27(2):173-9. (PMID: 9929499)

>  <Comments>  (69) 


$$$$
CC02422
     RDKit          3D

 33 36  0  0  0  0  0  0  0  0999 V2000
   -0.0170    1.3830    0.0100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0020   -0.0040    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2080   -0.6770   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3960    0.0300   -0.0210 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3800    1.4130   -0.0130 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1760    2.0910    0.0020 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2020    2.0480    0.0190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8930    3.4430    0.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1920    4.2520    0.0360 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9090    4.0090    1.2900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7660    4.7290    2.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5580    4.2360    3.3470 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2500    3.1600    2.7750 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8260    3.0430    1.4990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2030    2.2180    0.6870 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8390    5.9000    2.6480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9760    6.4240    4.0780 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2480    2.3170    3.4390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5510    1.1260    4.1000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5930    0.2460    4.7930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9240   -0.8980    5.4270 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.9820   -1.8200    5.8580 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3660   -2.9810    6.6390 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7220   -2.4720    7.8560 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6640   -1.5500    7.4250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2800   -0.3880    6.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0860   -3.5590    8.4590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3840   -3.3850    9.6440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7600   -4.4640   10.2410 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8360   -5.7180    9.6590 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5350   -5.8940    8.4790 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1600   -4.8190    7.8770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8810   -4.2480   11.7220 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1  7  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 14  1  0
 11 12  2  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  2  0
 16 17  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 27  1  0
 25 26  1  0
 27 28  2  0
 27 32  1  0
 28 29  1  0
 29 30  2  0
 29 33  1  0
 30 31  1  0
 31 32  2  0
M  END
>  <Name>  (70) 
Nefazodone

>  <InChIKey>  (70) 
VRBKIVRKKCLPHA-UHFFFAOYSA-N

>  <PubChem_CID>  (70) 
4449

>  <CYP1A2>  (70) 


>  <CYP2A6>  (70) 


>  <CYP2B6>  (70) 


>  <CYP2C8>  (70) 


>  <CYP2C9>  (70) 


>  <CYP2C19>  (70) 


>  <CYP2D6>  (70) 


>  <CYP2E1>  (70) 


>  <CYP3A4>  (70) 
<15,H;Hydroxylation;R1>
<1,H;Hydroxylation;R2>
<7,8;Cleavage;R3>
<7,H;Oxidation;R3>

>  <References>  (70) 
von Moltke LL, Greenblatt DJ, Granda BW, Grassi JM, Schmider J, Harmatz JS, Shader RI: Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions. Psychopharmacology (Berl). 1999 Jul;145(1):113-22. (PMID: 10445380)

>  <Comments>  (70) 


$$$$
CC02431
     RDKit          3D

 18 20  0  0  0  0  0  0  0  0999 V2000
    0.0990   -0.7470    0.2310 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9340    0.0320   -0.5790 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0150    0.1960    0.9120 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4970   -1.6840    1.3030 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0020   -1.5960   -0.6940 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5970    0.6960   -1.7730 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2410    0.1650   -0.0940 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4020    1.4960    1.2930 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1160    0.3460   -0.0440 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1990   -2.8980    0.6510 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3160   -2.8220   -1.3430 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5080    1.5220   -2.4450 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1720    0.9760   -0.7480 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4580    2.4980    1.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1830    1.2710    0.5550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2100   -3.7190   -0.2080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7900    1.6730   -1.9030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5410    2.6590    0.7340 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  2  0
  2  7  1  0
  3  8  1  0
  3  9  1  0
  4 10  1  0
  5 11  1  0
  6 12  1  0
  7 13  2  0
  8 14  1  0
  9 15  1  0
 10 16  1  0
 11 16  1  0
 12 17  2  0
 13 17  1  0
 14 18  1  0
 15 18  1  0
M  END
>  <Name>  (71) 
Phencyclidine

>  <InChIKey>  (71) 
JTJMJGYZQZDUJJ-UHFFFAOYSA-N

>  <PubChem_CID>  (71) 
6468

>  <CYP1A2>  (71) 


>  <CYP2A6>  (71) 


>  <CYP2B6>  (71) 


>  <CYP2C8>  (71) 


>  <CYP2C9>  (71) 


>  <CYP2C19>  (71) 


>  <CYP2D6>  (71) 


>  <CYP2E1>  (71) 


>  <CYP3A4>  (71) 
<13,H;Hydroxylation;R1>

>  <References>  (71) 
Laurenzana EM, Owens SM: Metabolism of phencyclidine by human liver microsomes. Drug Metab Dispos. 1997 May;25(5):557-63. (PMID: 9152594)

>  <Comments>  (71) 


$$$$
CC02440
     RDKit          3D

 61 66  0  0  0  0  0  0  0  0999 V2000
    1.9500    3.4530   -1.0200 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6740    2.1010   -1.5600 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0920    3.8200   -0.2850 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9450    4.4200   -1.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2970    1.7380   -1.9800 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4680    1.0940   -1.7840 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4620    5.1840   -0.2190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0590    3.1060    0.5750 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3890    4.0390   -1.7370 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2730    5.7730   -1.0500 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7060    2.6680   -1.9740 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2960    0.4180   -2.3780 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7020    0.0010   -2.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7110    5.3410    0.3110 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5300    6.1410   -0.6000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8810    4.2340    1.2200 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.1760    1.9080    0.7350 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2260    4.9000   -1.9470 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3480    6.7290   -1.3080 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1390    2.2510   -2.1570 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1520   -0.2260   -3.8280 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8790   -1.2930   -1.5880 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8930    7.6020   -0.5240 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2160    3.8530    1.4510 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1700    4.6340    2.5250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6550    1.8900   -0.7830 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5890   -0.7500   -3.8330 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3280   -1.7690   -1.7140 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3850    3.7840    2.7990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5830    2.6880   -0.1060 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2520    0.8750   -0.2500 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6530   -2.0280   -3.1190 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0880    2.6880    3.4680 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5920    2.7720    1.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6020    3.4780   -0.8940 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5720   -2.8660   -3.6550 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2040    2.6650    4.9710 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.5790    2.1010    2.0560 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6600   -4.2650   -3.0420 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9340    2.0540    5.5690 C   0  0  2  0  0  0  0  0  0  0  0  0
    7.3350    1.8790    5.3490 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5420    2.3010    3.3780 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4630   -5.1000   -3.5030 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9560   -4.9390   -3.4930 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9200    3.1520    5.8900 C   0  0  2  0  0  0  0  0  0  0  0  0
    5.2900    1.3010    6.8530 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4520    2.7680    5.4150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4900    1.6290    4.2250 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.6920    2.5350    6.5650 C   0  0  1  0  0  0  0  0  0  0  0  0
    3.5160    3.8110    4.6610 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9210    2.6380    5.2260 C   0  0  1  0  0  0  0  0  0  0  0  0
   -2.1170    0.4570    4.9820 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4170    3.1340    5.9690 C   0  0  1  0  0  0  0  0  0  0  0  0
    2.6960    1.0220    6.3410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7370    4.9040    4.7100 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3310    2.0580    5.8880 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.5820    3.8460    4.5430 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9630    4.2060    6.7980 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9330    5.3110    3.5030 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6820    5.5610    5.7230 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0150    1.5750    7.2980 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  2  5  1  0
  2  6  2  0
  3  7  1  0
  3  8  1  0
  4  9  1  0
  4 10  2  0
  5 11  2  0
  5 12  1  0
  6 13  1  0
  7 14  1  0
  7 15  2  0
  8 16  1  0
  8 17  2  0
  9 11  1  0
  9 18  2  0
 10 15  1  0
 10 19  1  0
 11 20  1  0
 12 13  1  0
 13 21  1  0
 13 22  1  0
 14 16  1  0
 15 23  1  0
 16 24  1  0
 16 25  1  1
 20 26  1  0
 21 27  1  0
 22 28  1  0
 24 29  1  0
 26 30  1  0
 26 31  2  0
 27 32  1  0
 28 32  1  0
 29 33  2  0
 30 34  2  0
 30 35  1  0
 32 36  1  0
 33 37  1  0
 34 38  1  0
 36 39  1  0
 37 40  1  0
 37 41  1  6
 38 42  2  0
 39 43  1  0
 39 44  1  0
 40 45  1  0
 40 46  1  1
 41 47  1  0
 42 48  1  0
 45 49  1  0
 45 50  1  6
 48 51  1  0
 48 52  1  1
 49 53  1  0
 49 54  1  6
 50 55  1  0
 51 56  1  0
 51 57  1  6
 53 56  1  0
 53 58  1  1
 55 59  1  0
 55 60  2  0
 56 61  1  1
M  END
>  <Name>  (72) 
Rifabutin

>  <InChIKey>  (72) 
CNAZMMBRYQFSBI-AEXANHCBSA-N

>  <PubChem_CID>  (72) 


>  <CYP1A2>  (72) 


>  <CYP2A6>  (72) 


>  <CYP2B6>  (72) 


>  <CYP2C8>  (72) 


>  <CYP2C9>  (72) 


>  <CYP2C19>  (72) 


>  <CYP2D6>  (72) 


>  <CYP2E1>  (72) 


>  <CYP3A4>  (72) 
<43,H;Hydroxylation;R1>
<47,H;Hydroxylation;R2>
<42,H;Hydroxylation;R3>
<0,1;Cleavage;R4>
<0,H;Oxidation;R4>

>  <References>  (72) 
Iatsimirskaia E, Tulebaev S, Storozhuk E, Utkin I, Smith D, Gerber N, Koudriakova T: Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents. Clin Pharmacol Ther. 1997 May;61(5):554-62. doi: 10.1016/S0009-9236(97)90135-1. (PMID: 9164417)

>  <Comments>  (72) 


$$$$
CC02449
     RDKit          3D

 33 37  0  0  0  0  0  0  0  0999 V2000
    0.0480    1.9660   -0.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0930    0.5870   -0.1220 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0240   -0.2210   -0.1200 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3110    0.3260   -0.1120 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4450    1.7050   -0.0800 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3150    2.5200   -0.0950 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3210   -0.5690   -0.1750 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5020   -0.1230    0.4600 C   0  0  2  0  0  0  0  0  0  0  0  0
    5.0820    1.0550   -0.3390 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.0240    2.4920    0.0100 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0510    2.7680   -0.1360 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5060   -1.2460    0.5050 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0560    0.7410   -1.8130 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8730    0.8520   -2.5210 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8460    0.5650   -3.8720 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0070    0.1650   -4.5180 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1920    0.0550   -3.8060 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2150    0.3480   -2.4560 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2810   -1.4350    1.6340 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1980   -2.4670    1.6800 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3410   -3.3150    0.5900 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5620   -3.1230   -0.5420 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6470   -2.0890   -0.5820 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9830   -0.1180   -5.8470 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2430   -4.3300    0.6320 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1550   -5.0130   -0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1500   -6.1750   -0.6390 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7630   -7.1670    0.3730 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8730   -8.1210    0.4740 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5390   -9.1960    1.5100 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2890   -9.9580    1.0590 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1520   -8.9580    0.8310 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6110   -7.8950   -0.1700 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  1 11  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  4  7  1  0
  5  6  2  0
  5 10  1  0
  7  8  1  0
  8  9  1  0
  8 12  1  6
  9 10  1  0
  9 13  1  6
 12 19  2  0
 12 23  1  0
 13 14  2  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 24  1  0
 17 18  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 25  1  0
 22 23  2  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
M  END
>  <Name>  (73) 
SERM-I

>  <InChIKey>  (73) 
TWZNCTCQAGRUGQ-RRPNLBNLSA-N

>  <PubChem_CID>  (73) 
448577

>  <CYP1A2>  (73) 


>  <CYP2A6>  (73) 


>  <CYP2B6>  (73) 


>  <CYP2C8>  (73) 


>  <CYP2C9>  (73) 


>  <CYP2C19>  (73) 


>  <CYP2D6>  (73) 


>  <CYP2E1>  (73) 


>  <CYP3A4>  (73) 
<23,28;Cleavage;R1>
<23,24;Cleavage;R1>
<28,H;Oxidation;R1>
<24,H;Oxidation;R1>
<6,S;S-Oxidation;R2>

>  <References>  (73) 
Zhang Z, Chen Q, Li Y, Doss GA, Dean BJ, Ngui JS, Silva Elipe M, Kim S, Wu JY, Dininno F, Hammond ML, Stearns RA, Evans DC, Baillie TA, Tang W: In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites. Chem Res Toxicol. 2005 Apr;18(4):675-85. doi: 10.1021/tx0496789. (PMID: 15833027)

>  <Comments>  (73) 


$$$$
CC02458
     RDKit          3D

 26 29  0  0  1  0  0  0  0  0999 V2000
   -7.6880    1.0150   -1.8570 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.6250    1.8170   -0.7000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8030    0.0020   -2.0250 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8180   -0.2320   -1.0320 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8580   -1.1210   -0.9400 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7770    0.5750    0.0900 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6900    1.5920    0.2400 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1750   -0.8940    0.2630 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7630    0.1550    0.8740 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4360    0.6380    1.9440 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0310   -1.6580    0.7660 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7330   -1.0250    0.2620 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5380   -1.8230    0.7870 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7080   -1.2140    0.3030 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8090   -2.0230    0.8400 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1470   -1.3770    0.4760 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2430   -0.0540    1.1060 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1420    0.7550    0.5690 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8050    0.1090    0.9320 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4280    0.5240    0.6450 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2390   -0.1670   -0.2460 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4110    0.4090   -0.7000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7750    1.6720   -0.2680 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9690    2.3620    0.6200 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7950    1.7940    1.0730 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4260   -0.4530   -1.8140 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  2  7  2  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  5  8  1  0
  6  7  1  0
  6  9  1  0
  8  9  1  0
  8 11  1  0
  9 10  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 20  1  0
 18 19  1  0
 20 21  2  0
 20 25  1  0
 21 22  1  0
 22 23  2  0
 22 26  1  0
 23 24  1  0
 24 25  2  0
M  END
>  <Name>  (74) 
Trazodone

>  <InChIKey>  (74) 
PHLBKPHSAVXXEF-UHFFFAOYSA-N

>  <PubChem_CID>  (74) 
5533

>  <CYP1A2>  (74) 


>  <CYP2A6>  (74) 


>  <CYP2B6>  (74) 


>  <CYP2C8>  (74) 


>  <CYP2C9>  (74) 


>  <CYP2C19>  (74) 


>  <CYP2D6>  (74) 


>  <CYP2E1>  (74) 


>  <CYP3A4>  (74) 
<5,6;Cleavage;R1>
<5,H;Oxidation;R1>
<13,H;Hydroxylation;R2>
<21,22;Epoxidation;R3>

>  <References>  (74) 
Wen B, Ma L, Rodrigues AD, Zhu M: Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine. Drug Metab Dispos. 2008 May;36(5):841-50. doi: 10.1124/dmd.107.019471. Epub 2008  Jan 31. (PMID: 18238857)

>  <Comments>  (74) 


$$$$
CC02467
     RDKit          3D

 16 17  0  0  0  0  0  0  0  0999 V2000
    1.3210    0.6530    0.0370 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1430    1.3790   -0.1080 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0700    0.6950   -0.1760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1890    1.4690   -0.3190 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3680    0.6740   -0.3770 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5500    1.5990   -0.5330 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.8200    0.7890   -0.5990 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0020    1.7130   -0.7550 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0840   -0.7010   -0.0970 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1060   -1.4150    0.0490 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3160   -0.7330    0.1160 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5720   -1.4340    0.2670 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7230   -0.7630    0.3300 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7550    0.7070    0.2480 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8070    1.3350    0.3050 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5330    1.3630    0.1030 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1 11  1  0
  1 16  1  0
  2  3  1  0
  3  4  1  0
  3  9  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
M  END
>  <Name>  (75) 
7-Butoxycoumarin

>  <InChIKey>  (75) 
BDOGTORASJEUBW-UHFFFAOYSA-N

>  <PubChem_CID>  (75) 
156219

>  <CYP1A2>  (75) 


>  <CYP2A6>  (75) 


>  <CYP2B6>  (75) 


>  <CYP2C8>  (75) 


>  <CYP2C9>  (75) 


>  <CYP2C19>  (75) 


>  <CYP2D6>  (75) 


>  <CYP2E1>  (75) 


>  <CYP3A4>  (75) 
<3,4;Cleavage;R1>
<3,H;Oxidation;R1>
<0,H;Hydroxylation;R2>
<1,H;Hydroxylation;R3>

>  <References>  (75) 
Khan KK, Halpert JR: Structure-function analysis of human cytochrome P450 3A4 using 7-alkoxycoumarins as active-site probes. Arch Biochem Biophys. 2000 Jan 15;373(2):335-45. doi: 10.1006/abbi.1999.1578. (PMID: 10620357)

>  <Comments>  (75) 


$$$$
CC02476
     RDKit          3D

 27 30  0  0  1  0  0  0  0  0999 V2000
    0.2500    0.2780    0.9490 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0030   -0.2950    1.2650 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0750   -1.5930    0.8410 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3450   -2.1280    0.0850 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.0840   -0.5870    0.2720 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4490   -0.3270   -0.1410 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8590   -0.7950   -1.4500 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2480    0.2670    0.5780 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1500   -1.2040   -1.8200 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2460   -1.5640   -3.0960 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9950   -1.3920   -3.5970 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1300   -0.8700   -2.6230 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5320   -1.6520   -4.8990 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3870   -2.2710   -5.9190 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2620   -1.3620   -5.2290 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4550   -0.7650   -4.1350 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8400   -0.5320   -2.9200 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1130   -3.4250   -5.6110 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9430   -4.0460   -6.5450 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6800   -5.2180   -6.2250 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5490   -5.7410   -7.2600 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6010   -5.8650   -4.9930 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5070   -7.0610   -4.8880 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8860   -5.5610   -4.0420 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0380   -3.4790   -7.8190 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3200   -2.3310   -8.1490 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4960   -1.7300   -7.2010 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  7  9  1  0
  7 12  2  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 12 17  1  0
 13 14  1  0
 13 15  2  0
 14 18  2  0
 14 27  1  0
 15 16  1  0
 16 17  2  0
 18 19  1  0
 19 20  1  0
 19 25  2  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 22 24  2  0
 25 26  1  0
 26 27  2  0
M  END
>  <Name>  (76) 
Indiplon

>  <InChIKey>  (76) 
CBIAWPMZSFFRGN-UHFFFAOYSA-N

>  <PubChem_CID>  (76) 
6450813

>  <CYP1A2>  (76) 


>  <CYP2A6>  (76) 


>  <CYP2B6>  (76) 


>  <CYP2C8>  (76) 


>  <CYP2C9>  (76) 


>  <CYP2C19>  (76) 


>  <CYP2D6>  (76) 


>  <CYP2E1>  (76) 


>  <CYP3A4>  (76) 
<3,4;Cleavage;R1>
<4,H;Oxidation;R1>

>  <References>  (76) 
Madan A, Fisher A, Jin L, Chapman D, Bozigian HP: In vitro metabolism of indiplon and an assessment of its drug interaction potential. Xenobiotica. 2007 Jul;37(7):736-52. doi: 10.1080/00498250701433054. (PMID: 17620220)

>  <Comments>  (76) 


$$$$
